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ABSTRACT 
 
Rebekah Stevenson: Characterization of Adolescent and Adult Ethanol Sensitization 
 
(Under the direction of Dr. Clyde Hodge) 
 
Alcoholism is a serious health problem that affects the lives of millions of people 
worldwide.  People that first experiment with alcohol as adolescents are at a greater risk 
to become alcoholics.  The adolescent brain may be particularly vulnerable to drug-
induced neuroadaptations.  Behavioral sensitization is a method that uses repeated drug 
exposure to induce neurobiological changes that are thought to model the changes 
taking place during addiction.  Sensitization to ethanol has not been studied in 
adolescents and is an important tool to aid in the understanding of ethanol-induced 
neuroadaptations that occur during development.  The research described in this 
dissertation entailed the study of the dose response and time course of ethanol 
sensitization in adolescent and adult mice.  The results indicate that adolescent mice are 
less sensitive to ethanol sensitization than adult mice.  The neurobiological mechanisms 
mediating ethanol sensitization have not been fully characterized.  One type of 
glutamate receptor, the metabotropic glutamate receptor subtype 5 (mGluR5), is 
involved in drug reinforcement, relapse, and reward processes, although it has not been 
studied in adolescent ethanol sensitization.  Results of the research described in this 
dissertation showed that mGluR5 is not involved in adolescent ethanol sensitization, 
while it is critical in adult ethanol sensitization.  This indicates that mGluR5 might 
underlie the differential response to ethanol sensitization in adolescent and adult mice. 
Finally, this research was designed to determine whether the differential response to 
ethanol sensitization makes the adolescent mice more susceptible to subsequent 
ii 
ethanol intake.  The results show that, following ethanol sensitization, the adolescent 
mice do not show increased ethanol intake, while the adult mice demonstrate a 
significant increase in ethanol intake and preference.  Overall, this dissertation shows for 
the first time that adolescent mice are less sensitive to ethanol sensitization than adult 
mice.  This difference in sensitization, however, does not appear to underlie the 
adolescent vulnerability to alcoholism that has been observed in humans. 
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 CHAPTER I:  GENERAL INTRODUCTION 
ADOLESCENCE 
 Adolescence (age 12-20 years in humans) is a developmental period 
characterized by numerous physical, behavioral, and cognitive changes.  The 
neurobiological systems that underlie these behavioral and cognitive changes mature at 
different rates, which leaves the adolescent with the difficult task of balancing increases 
in emotional and hormonal drive with increases in decision-making abilities (Steinberg 
2005).  Behaviorally, adolescents spend an increased amount of time engaged in social 
interaction with peers, taking part in risky behaviors, and exploring novel situations 
(Primus and Kellogg 1989; Spear 2000b).  Cognitively, adolescents develop abstract 
thinking skills, show improvements in executive functions and reasoning, and begin to 
develop adult-levels of decision making (Keating 2004).  Interestingly, evidence shows 
that adolescents take part in dangerous activities despite knowing the risks involved, and 
this discrepancy is due to social and emotional influences (Martin et al. 2002; Slovic 
1987).  Adolescence appears to be a unique period of competing social, emotional, and 
intellectual influences.         
 
THE ADOLESCENT BRAIN 
 During adolescence, the mesolimbic dopamine system and the prefrontal cortex 
undergo numerous changes (Crews et al. 2007; Spear 2000b).  Dopamine receptors are 
overexpressed in both limbic and prefrontal cortical regions, and this increase is followed 
by massive pruning of dopamine receptors in the limbic system compared to the 
prefrontal cortex (Kalsbeek et al. 1988; Lewis 1997; Rakic et al. 1994).  This leads to an
overall dominance of the mesocortical dopaminergic pathway compared to the 
mesolimbic pathway.  Overall, the prefrontal cortex takes much longer than the limbic 
system to develop during adolescence (Bourgeois et al. 1994; Huttenlocher 1979).  
Glutamatergic synapses show a burst at puberty, followed by pruning after puberty 
(Huttenlocher 1984; Insel et al. 1990; Rakic et al. 1994).  The result of synapse pruning 
is more focal activity in the prefrontal cortex, which can be viewed as more efficient 
information processing (Durston et al. 2006).  It is likely that the developing mesocortical 
dopamine system modulates the synaptic pruning of the prefrontal cortex, such that 
rewarding stimuli are able to create stronger synaptic connections in the prefrontal 
cortex (Davey et al. 2008).  This could underlie the known vulnerability for drug use 
during adolescence to lead to drug abuse problems in adulthood (Grant and Dawson 
1998).    
 
ADOLESCENCE AND DRUG ABUSE 
 The behavioral and neurobiological changes that take place during this 
developmental stage cause the adolescent to be particularly vulnerable to experimenting 
with drugs of abuse and to subsequent drug-induced neuroadaptations (Crews et al. 
2007; Spear 2002).  In fact, seventy-five percent of twelfth graders have experimented 
with alcohol in their lifetime, and almost thirty percent of these adolescent drinkers have 
consumed five or more drinks in the last two weeks (O'Malley et al. 1998).  Symptoms of 
alcohol dependence can emerge at an accelerated rate in adolescents compared to 
adults (Clark et al. 1998; Pollock and Martin 1999).  It is known that people who start 
drinking during adolescence are four times more likely to become alcohol dependent as 
adults (Grant 1998).  Altogether, it seems that adolescence is a period of unique 
susceptibility to drug and alcohol intake and to future drug and alcohol problems. 
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Similar to the clinical findings in human adolescents, studies in rodents have 
shown that adolescents and adults are differentially sensitive to the effects of ethanol.  
Adolescent rodents (age 28 – 42 days) are more sensitive to the effects of acute and 
chronic ethanol on measures of locomotor stimulation, anxiety, ataxia, spatial memory, 
binge-induced brain damage, conditioned place preference, and social interaction as 
compared to adult rats (Crews et al. 2000; Hefner and Holmes 2007; Markwiese et al. 
1998; Philpot et al. 2003; Rajendran and Spear 2004; Varlinskaya and Spear 2002; Yttri 
et al. 2004).  By contrast, other studies have shown that adolescent rodents are less 
sensitive than adult rats to the sedative and motor-impairing effects of ethanol, to 
ethanol withdrawal-induced anxiety, and analgesia (Doremus et al. 2003; Hefner and 
Holmes 2007; Silveri and Spear 1998; Varlinskaya and Spear 2002; White et al. 2002).  
These differences in the sensitivity of adolescents to ethanol are important because it 
has been shown that a decreased response to acute alcohol challenge during 
adolescence is a potent predictor of future alcoholism (Schuckit 1993; 1994).  At the 
present time, it remains unknown precisely what mechanisms underlie differences in 
sensitivity between adolescent and adult rodents. Identifying the neurobehavioral 
adaptations that underlie differential sensitivity during development is important to 
understanding how alcohol exposure early in life predisposes people to subsequent 
development of addiction.   
 
ALCOHOLISM 
Alcoholism is a disease that affects the lives of most people.  Over 7% of the 
United States population is alcoholic which leads to annual costs of more than $180 
billion (Harwood et al. 1998).  Clinically, alcoholism is defined in the DSM-IV as an 
impaired ability to control the drinking of alcohol.  This impairment manifests itself as 
craving, a lack of ability to stop drinking once drinking has begun, physical dependence, 
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tolerance, preoccupation with alcohol consumption, lack of interest in other life activities 
besides drinking alcohol, and continued alcohol use despite physical and psychological 
problems.  Withdrawal symptoms include autonomic hyperactivity, tremor, nausea or 
vomiting, anxiety, and seizure, while tolerance is defined as a need for more alcohol in 
order to obtain the same level of intoxication. 
 Addiction to ethanol and other drugs of abuse arises from an interaction 
between various genetic, environmental, and neurobiological factors (Goldstein and 
Volkow 2002). Although the mechanisms underlying addiction have not been fully 
characterized, it is well known that dopamine (DA) is a key neurotransmitter which 
modulates addiction through the mesocorticolimbic pathway (Volkow et al. 2002).  This 
pathway is critical in integrating inputs from sensory systems, emotional state, memory, 
and attention systems, and keeping these systems in a balance.  Ethanol exerts its 
effects on numerous neurotransmitter receptors (ie GABAA and NMDA) throughout this 
pathway.  It is postulated that changes to the signaling along this path by repeated 
ethanol exposure can lead to ethanol dependence (Kiianmaa et al. 2003).  This pathway 
is characterized by dopaminergic neuronal projections from the ventral tegmental area 
(VTA) to the nucleus accumbens (NAc), and this has been shown to be important for the 
reinforcing and rewarding properties of drugs of abuse (Everitt and Wolf 2002).  Ethanol 
interacts with this pathway by causing an increase in dopamine in the NAc due to 
increased firing of the VTA DA neurons.  Animal studies using self-administration and 
knockout mice have shown that this interaction seems critical to the subjective rewarding 
effects of ethanol (Weiss and Porrino 2002).   
 
ALCOHOLISM AND GLUTAMATE 
Studies have begun to show the importance of the glutamate system for the 
behavioral effects of ethanol and alcoholism (Krystal et al. 2003).  Glutamate is a 
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prominent neurotransmitter in the cerebral cortex and in limbic areas of the brain, 
suggesting a key role of glutamate transmission in the process of addiction.  It is known 
that glutamatergic neurotransmission modulates dopaminergic neurotransmission in the 
mesocorticolimbic pathway (Tsai and Coyle 1998).    
Much of this research has focused on the NMDA glutamate receptor, as it is 
known that this receptor has a high affinity site for ethanol (Grant and Lovinger 1995).  
NMDA receptors are unique in that they are ligand-gated ion channels that also have 
voltage dependency.  This means that in order for the channel to allow ions through, 
glutamate must bind and the membrane must be depolarized.  Depolarization removes 
the Mg2+ block of the receptor, allowing both Na+ and Ca2+ to flow into the cell.  The Ca2+ 
that enters the cell can modulate gene transcription and protein expression, which are 
critical to the function of NMDA receptors (Morgan and Curran 1988).  NMDA receptors 
consist of 2 variable subunits which determine where the receptor is expressed and the 
precise function of the receptor (Krystal et al. 2003).   
The exact interaction of ethanol with NMDA receptors is not known, although it 
appears that when given acutely, ethanol binds to a hydrophobic pocket on the receptor 
(Peoples and Weight 1995).  This binding inhibits the influx of Ca2+ into the cell, which is 
critical to ethanol’s effects (Wirkner et al. 1999).  Chronic ethanol exposure leads to an 
increase in NMDA receptor number and function in brain regions known to be important 
in addiction, namely the cerebral cortex, striatum, thalamus, and hippocampus (Tsai and 
Coyle 1998).  This upregulation in receptor number is important to the withdrawal 
syndrome, a key feature of alcoholism. An increase in glutamate release is noticed 
during withdrawal, and this increase is directly related to the increase in NMDA receptor 
number and function (Rossetti and Carboni 1995; Tsai and Coyle 1998).  Treatment with 
MK-801, an NMDA receptor antagonist, reduces many of the physical signs of 
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withdrawal, along with reducing the increase in glutamate release (Grant et al. 1992; 
Tsai and Coyle 1998).   
Pathways that lead to feelings of reward from drugs of abuse are implicated in 
the process of addiction.  NMDA receptors are known to be expressed throughout the 
mesocorticolimbic pathway, with high areas of expression in the hippocampus, frontal 
cortex, nucleus accumbens, striatum, and amygdala (Cotman and Monaghan 1986; 
Hodge and Cox 1998).  NMDA receptors can affect the release of dopamine along this 
pathway when ethanol is administered.  Ethanol inhibits NMDA receptors, which in turn 
inhibit GABAergic interneurons, which then leads to a disinhibition of the forebrain 
glutamatergic neurons, leading to an augmentation of dopamine release (Nestler et al. 
1993).  
 
METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 (mGluR5) 
  Another glutamate receptor that has recently been shown to be critical for 
ethanol’s effects is the metabotropic glutamate receptor subtype 5 (mGluR5).  
Metabotropic glutamate receptors (mGluRs) are a class of G-protein coupled receptors 
that are divided into three groups based on sequence homology, agonist pharmacology, 
and the signal transduction cascade initiated at the receptor.  Group I mGluRs (mGluR1 
and mGluR5) are positively coupled to phospholipase C, which activates signaling 
through diacylglycerol (See Figure 1).  Group II (mGluR2/3) and Group III (mGluRs 4, 6, 
7, and 8) mGluRs inhibit adenylyl cyclase activity, and thus inhibit signaling through 
cyclic- AMP (Conn and Pin 1997).  
 MGluR5 are expressed abundantly in the nucleus accumbens and ventral 
tegmental area, where they interact with dopamine to generate locomotor activity 
(Swanson and Kalivas 2000; Vezina and Kim 1999).  MGluR5 knockout mice show no 
cocaine-induced enhancement of locomotor activity and do not self-administer cocaine, 
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indicating that mGluR5’s interact with dopamine signaling in the nucleus accumbens to 
effect drug reward (Chiamulera et al. 2001).  It has also been shown that mGluR5 and 
D1R interact in the striatum to modify signal transduction pathways (Voulalas et al. 
2005).  Thus, mGluR5’s have the potential to be involved in many of the rewarding 
properties of drugs and in addiction. 
 Ethanol is known to modulate mGluR activity based on in vitro and in vivo 
studies.  In cultured Purkinje neurons, ethanol inhibits the burst activity mediated by 
mGluRs (Netzeband and Gruol 1995).  Ethanol also has been shown to inhibit mGluR5 
function in Xenopus oocytes (Minami et al. 1998).  Behavioral studies have shown that 
antagonism of mGluR5 reduces ethanol self-administration and blocks the discriminative 
stimulus properties of ethanol (Backstrom et al. 2004; Besheer and Hodge 2004; Hodge 
et al. 2006; Olive et al. 2005; Schroeder et al. 2005).  Overall, glutamatergic signaling 
through mGluR5’s appears to be critical for ethanol’s rewarding properties. 
Figure 1.  Glutamate Signaling Pathways. 
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Figure 1.  Intracellular signaling following the activation of glutamate receptors.  
Activation of the mGluR5’s can activate numerous downstream targets, including Ca2+, 
CaMKII, and ERK1/2.  These signaling molecules can effect long-term changes in gene 
expression and neuronal function. 
 
 
LOCOMOTOR SENSITIZATION 
 Behavioral sensitization is a model that can be used to study the 
neuroadaptations that occur following repeated drug exposure.  Sensitization is typically 
shown as a progressive increase in locomotor activity following repeated administration 
of a single dose of a drug of abuse.  For example, repeated administration of 
psychostimulants leads to an increase in locomotor activity, which is thought to be 
analogous to increases in anxiety and paranoia seen in human stimulant abusers 
(Pierce and Kalivas 1997).  One theory of behavioral sensitization proposes that drug 
craving sensitizes with repeated use, which makes the study of sensitization extremely 
important in understanding the mechanism of addiction (Robinson and Berridge 1993).  
Research has shown that sensitization is mediated by an interconnected network of 
mesocorticolimbic brain regions (i.e., VTA, nucleus accumbens, prefrontal cortex, 
amygdala, and thalamus) and neurotransmitter systems (i.e., dopamine, glutamate, and 
GABA) that all undergo alterations during the adolescent developmental period (Kalivas 
1995; Spear 2000a; Vezina and Kim 1999).  Thus, studying sensitization during 
adolescence may elucidate specific age-dependent mechanisms by which drugs alter 
brain and behavioral functions.  Also, since these neural systems play key roles in 
alcohol and drug reinforcement during adulthood (Koob 2000; McBride et al. 1999), age-
dependent differences in sensitization may influence the increased probability of 
developing dependence in adulthood.   
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Figure 2. Neurocircuitry of Locomotor Sensitization. 
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Figure 2.  Neurocircuitry changes induced by sensitization.  Proposed changes that 
occur due to locomotor sensitization in adult mice, adapted from Pierce and Kalivas 
1993.  Locomotor sensitization occurs following an increase in dopaminergic 
neurotransmission from the VTA to the NAc (bold blue arrow), along with increases in 
glutamatergic neurotransmission from the PFC to the NAc (bold red arrow). Dashed 
lines indicate a decrease in neurotransmission.  VTA=ventral tegmental area; 
NAc=Nucleus Accumbens; PFC=Prefrontal Cortex; VP=Ventral Pallidum; MD 
Thal=Medial dorsal Thalamus 
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ETHANOL LOCOMOTOR SENSITIZATION 
Like other drugs of abuse, ethanol is known to be a locomotor stimulant at low 
doses (up to 2.5 g/kg).  Since the rewarding properties of drugs are thought to be 
positively correlated with locomotor activation (Wise and Bozarth 1987), studying ethanol 
sensitization has the potential to identify adaptations that may influence reward (Phillips 
et al. 1997).  Ethanol sensitization has been primarily studied in adult mice. Researchers 
use various protocols to induce ethanol sensitization, with all involving repeated 
administration of ethanol over a number of days.  The dose of ethanol used to induce 
locomotor sensitization commonly ranges from 1.5 g/kg to 3.5 g/kg, given for anywhere 
between 4 and 21 days (Broadbent and Harless 1999; Broadbent and Weitemier 1999; 
Fish et al. 2002; Itzhak and Martin 2000; Lessov et al. 2001; Meyer and Phillips 2003; 
Miquel et al. 2003; Quadros et al. 2003).  The time course of the development of ethanol 
sensitization has been studied in adult DBA/2J mice, with the mice developing 
sensitization after three ethanol exposures (Lessov et al. 2001).  Ethanol sensitization 
has been shown to last up to 29 days after the final ethanol treatment, indicating that 
lasting neurobiological changes occur during sensitization (Lessov and Phillips 1998).   
Studies have shown that baclofen, the GABA(B) agonist, and 7-nitroindazole, an 
inhibitor of neuronal nitric oxide synthase, and a corticotropin releasing factor-1 receptor 
antagonist all prevent the expression of ethanol sensitization (Broadbent and Harless 
1999; Fee et al. 2007; Itzhak and Martin 2000).  Furthermore, the glutamatergic NMDA 
receptor antagonist MK-801, the mGluR5 antagonist MTEP, and the AMPA antagonist 
GYKI 52466 all inhibit ethanol sensitization (Broadbent et al. 2003; Broadbent and 
Weitemier 1999; Kotlinska et al. 2006) indicating a definitive role for glutamatergic 
signaling in the development of ethanol sensitization.  Thus, studying ethanol 
sensitization in adolescent and adult mice might lead to insights in the glutamatergic 
mechanisms that mediate addiction-related behaviors. 
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DBA/2J MICE   
The DBA/2J inbred strain of mice show strong locomotor activation to ethanol 
and display conditioned place preference to ethanol (Cunningham et al. 1992; Phillips et 
al. 1994).  Although DBA/2J mice will not orally self-administer ethanol due to a taste 
aversion, they do self-administer ethanol intravenously and intragastrically, indicating 
that ethanol is rewarding (Grahame and Cunningham 1997; Risinger et al. 1998); 
Cunningham et al., 2005).  Furthermore, it has been shown by our lab that DBA/2J mice 
will self-administer ethanol following ethanol sensitization, indicating that pre-exposure to 
ethanol will induce ethanol drinking in these mice (Camarini and Hodge 2004).  Finally, 
ethanol induces stronger excitation from ventral tegmental dopamine neurons in DBA/2J 
mice than in C57BL/6J mice, which might underlie the behavioral effects of ethanol in 
DBA/2J mice (Brodie and Appel 2000).  Overall, DBA/2J mice offer an excellent model to 
study the neurobiological effects of ethanol.    
 
EXPERIMENTAL DESIGN / HYPOTHESES 
Adolescence in humans and rodents appears to be a unique period of sensitivity 
to drugs of abuse, including ethanol.  Studying ethanol sensitization offers a method to 
assess the neuroadaptations that occur due to ethanol exposure during adolescence. It 
is hypothesized that adolescent mice are less sensitive to the dose response and time 
course of ethanol sensitization. As glutamate neurotransmission is involved in 
adolescent development, alcoholism and ethanol sensitization, the study of the 
glutamate mGlu5 receptor in adolescent and adult ethanol sensitization may provide 
insight into the mechanisms mediating differential adolescent sensitivity to ethanol. It is 
hypothesized that mGluR5 is involved in adult, but not adolescent, ethanol sensitization.    
Ethanol self-administration following ethanol sensitization can be utilized to determine 
whether the neuroadaptations that occur during ethanol sensitization in adolescence are 
 11
relevant to the adolescent vulnerability to future alcoholism.  Therefore, it is 
hypothesized that adolescent mice self-administer more ethanol following ethanol 
sensitization than adult mice.  Overall, these studies have the potential to extend the 
current knowledge of neurobiological differences between adolescent and adult mice 
and provide new insight into the mechanisms by which adolescent alcohol use increases 
the probability of alcoholism in adulthood (Figure 3). 
 
Figure 3: Dissertation Overview 
 
 
 
 
 
 
 
 
 
 
 
 
Overview
Differential response to ethanol sensitization 
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sensitization
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ERK
Comparison to cocaine 
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Figure 3: Dissertation Overview. The experiments in this dissertation will first determine 
the dose response and time course to ethanol sensitization in adolescent and adult mice.  
The role of the mGlu5 receptor in ethanol sensitization will be determined. Finally, the 
hypothesis that ethanol sensitization during adolescence leads to an increase in 
subsequent ethanol self-administration will be tested. 
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CHAPTER II: COMPARISON OF ETHANOL LOCOMOTOR SENSITIZATION IN 
ADOLESCENT AND ADULT DBA/2J MICE 
INTRODUCTION 
Adolescence is a critical period of development during which children and young 
animals undergo adaptive changes in behavior and neurobiological systems that bring 
about the transition into adulthood.  Behavioral changes include spending an increased 
amount of time engaged in social interaction with peers, taking part in risky behaviors, 
and exploring novel situations, while neurobiological changes include remodeling in the 
cortex and mesolimbic regions such that glutamatergic and GABAergic 
neurotransmission is reduced and dopaminergic neurotransmission is increased (Spear 
2000a). 
 The behavioral and neurobiological adaptations that take place during this 
developmental stage cause the adolescent to be particularly vulnerable to experimenting 
with drugs of abuse and to subsequent drug-induced neuroadaptations (Crews et al. 
2007; Spear 2002).  The study of ethanol exposure during the adolescent period is 
important because it is known that people who start drinking during adolescence are four 
times more likely to become alcohol dependent as adults (Grant 1998).  However, the 
mechanism(s) underlying this finding remain to be fully characterized.   
Studies in rodents have shown that adolescents and adults are differentially 
sensitive to the effects of acute and chronic ethanol.  Adolescent rodents are more 
sensitive to the effects of acute and chronic ethanol on measures of locomotor 
stimulation, anxiety, ataxia, spatial memory, conditioned place preference, and social 
interaction as compared to adult rats (Hefner and Holmes 2007; Markwiese et al. 1998; 
 
 14
Philpot et al. 2003; Rajendran and Spear 2004; Varlinskaya and Spear 2002; Yttri et al. 
2004).  By contrast, other studies have shown that adolescent rodents are less sensitive 
than adult rats to the sedative and motor impairing effects of ethanol, to ethanol
withdrawal induced anxiety, and analgesia (Doremus et al. 2003; Hefner and Holmes 
2007; Silveri and Spear 1998; Varlinskaya and Spear 2002; White et al. 2002).  These 
differences in the sensitivity of adolescents to ethanol are important because it has been 
shown that a decreased response to acute alcohol challenge during adolescence is a 
potent predictor of future alcoholism (Schuckit 1993; 1994).   
One model of neurobehavioral adaptations that occur following chronic ethanol 
exposure is locomotor sensitization.  Sensitization is typically defined as a progressive 
increase in locomotor activity following repeated administration of a drug of abuse 
(Kalivas and Stewart 1991).  The process of sensitization is thought to produce enduring 
adaptive changes in brain and behavioral function that may underlie components of 
addiction (Kalivas et al. 1998; Robinson and Berridge 2000).  Research has shown that 
sensitization is mediated by an interconnected network of mesocorticolimbic brain 
regions (i.e., VTA, nucleus accumbens, prefrontal cortex, amygdala, and thalamus) and 
neurotransmitter systems (i.e., dopamine, glutamate, and GABA) (Kalivas 1995; Vezina 
and Kim 1999).  These brain regions and neurotransmitter systems all undergo 
alterations during the adolescent developmental period (Kalivas 1995; Spear 2000a; 
Vezina and Kim 1999).  Thus, sensitization models are useful tools to determine if 
adolescent vulnerability to addiction involves differential sensitivity to neurobehavioral 
changes that occur with repeated drug use.   
Various protocols have been used to induce ethanol locomotor sensitization, all 
of which involve repeated administration of ethanol over a number of days.  The dose of 
ethanol used to induce locomotor sensitization commonly ranges from 1.5 g/kg to 2.5 
g/kg, administered for 4 to 21 days (Broadbent and Harless 1999; Broadbent and 
Weitemier 1999; Fish et al. 2002; Itzhak and Martin 2000; Lessov et al. 2001; Meyer and 
Phillips 2003; Miquel et al. 2003; Quadros et al. 2003).  In adult DBA/2J mice, 
sensitization develops after three ethanol exposures and persists up to 68 days after the 
final ethanol treatment (Fish et al. 2002; Lessov et al. 2001). These studies indicate that 
long-lasting neurobiological changes occur during sensitization.  Importantly, ethanol 
locomotor sensitization has not been studied in adolescent rodents.   
The present study was designed to examine potential developmental differences 
in sensitivity to the neurobehavioral adaptations that occur during the induction of 
ethanol sensitization. Given the differential behavioral responses to ethanol in 
adolescents and adults, this study sought to fully characterize ethanol dose response 
and time course for sensitization in both adolescent and adult mice.      
 
MATERIALS AND METHODS 
Animals.  Male 3-week old (adolescent) and 8-week old (adult) DBA/2J mice 
(Jackson Laboratories, Bar Harbor, ME) were housed in groups (4 animals per cage) in 
standard Plexiglas cages with food (Purina Rodent Chow) and water available ad 
libitum.  The colony was maintained at 27oC on a 12-hour light/dark cycle, with the lights 
on at 10pm.  The behavioral experiments were conducted during the dark portion of the 
cycle.  Mice were handled and weighed daily for 1-week prior to, and for the duration of, 
the experiment.  Animals were under continuous care and monitoring by the Division of 
Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were carried out in 
accordance with the NIH Guide to Care and Use of Laboratory Animals (National 
Research Council, 1996) and Institutional guidelines. 
 Behavioral Apparatus.  The locomotor activity (horizontal distance traveled, cm) 
of adolescent and adult mice was measured in eight covered Plexiglas chambers (30 
cm2, Med Associates, Georgia, VT).  Two sets of 16 pulse-modulated infrared 
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photobeams were located on opposite walls to record ambulatory movements in the X-Y 
(horizontal) plane.  All software settings were the same for adult and adolescent mice.  
The activity chambers were computer-interfaced (Med Associates) for data sampling at 
100-millisecond resolution.   
Behavioral Procedures.  Mice were adapted to the colony and to handling for 1-
week (adolescents=P28; adults=P63).  On locomotor testing days, mice were taken in 
the home cage to the testing room at least 30-minutes prior to the session to habituate to 
the testing room.  The first two days of the each experiment were habituation days (H1 
and H2).  On these days, all mice received an intraperitoneal (IP) injection of saline and 
were immediately placed in the locomotor chamber for the 10 minute session.   
Experiment 1a: Acute Locomotor Activity.  Adolescent and adult mice received 
an IP injection of 0, 1.0, 1.5, 2.0, or 2.5 g/kg ethanol (n=8 per age group per ethanol 
dose) and were immediately placed in the locomotor chamber for the 10 minute session.   
Experiment 1b: Sensitization Dose Response.  Following the acute locomotor 
session on day 1 (D1), mice received the assigned ethanol dose (0, 1.5, 2.0, 2.5, or 3.0 
g/kg IP) once daily for nine days (D2-D10) in the home cage.  On day 11 (D11), the mice 
were tested for locomotor sensitization.  Mice were injected with 0, 1.0, 1.5, 2.0, or 2.5 
g/kg ethanol (IP) and placed in the locomotor chamber for 10 minutes (Lessov and 
Phillips 1998). 
Experiment 2a: Sensitization Time Course.   On day 1 (D1), the mice received an 
IP injection of 0, 2.0, or 2.5 g/kg ethanol (n=8 per age group per ethanol dose per length 
of treatment) and were immediately placed in the locomotor chamber for 10 minutes.  
For the following days (D2-D6 or D2-D10) mice received the assigned ethanol dose (0, 
2.5, or 3.0 g/kg IP) once daily and were returned to the home cage.  On day 7 or 11 (D7 
or D11), the mice were tested for locomotor sensitization.  Mice were injected with 2.0 or 
2.5 g/kg ethanol (IP) and placed in the locomotor chamber for 10 minutes.   
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Experiment 2b.  Mice received ethanol (2.0 g/kg) on D1, followed by daily (D2-
14) treatment with ethanol (2.5 g/kg; n=8 per age group).  On day 15, mice were tested 
for locomotor sensitization to ethanol (2.0 g/kg).    
Experiment 3: Blood Ethanol Determination.  Tail blood was collected from 
adolescent and adult mice at 10, 60, and 180 minutes after an initial ethanol (2.0 g/kg) 
injection (D1; n=6-8 per age group).  Mice were then treated with ethanol (2.5 g/kg) for 
the following nine days (D2-D10).  Tail blood was collected again on day 11 (D11) of 
ethanol (2.0 g/kg; n=6-8 per age group) administration at 10, 60, and 180 minutes post-
injection.  Individual blood samples were centrifuged and 5 μL of plasma from each 
sample was analyzed to determine blood ethanol concentration using an AM1 Alcohol 
Analyzer (Analox Instruments, Lunenburg, MA). 
Drugs.  Ethanol (95% w/v) was diluted in saline (0.9%) to a concentration of 20% 
(v/v) and injected at different volumes to achieve the appropriate dosage (i.e., 2.0 and 
2.5 g/kg).  Control animals received 0.9% saline. 
Behavioral Measures and Data Analysis.  Horizontal distance traveled (in 
centimeters) during the 10-minute session was calculated from the number of 
photobeam breaks and presented as mean ± SEM.  The distance traveled on 
habituation days 1 and 2 was compared between adolescent and adult mice using an 
unpaired t-test.  Statistical significance was defined as p≤0.05 in all experiments.      
Experiment 1a.  Acute Locomotor Activity.  The total distance traveled (cm) after 
an acute injection of saline or ethanol was examined using 2-way ANOVA with age 
(adolescent and adult) and ethanol dose as factors.  Post-hoc Tukey tests were used to 
determine between group differences.   
Experiment 1b.  Sensitization: Dose Response.  Distance traveled (cm) was 
analyzed for the adolescents and adults using three-way repeated measure (RM) 
ANOVA, with age (adolescent and adult), day (D1 and D11), and ethanol dose as 
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factors.  Significant interactions were followed with analysis by lower order (e.g., two-
way) ANOVA where appropriate.  Sensitization was defined as activity on day 11 being 
significantly greater than activity on day 1 within an ethanol dose, as determined by post-
hoc Tukey tests. This within group definition of sensitization was applied because it was 
observed that groups of adolescent and adult mice treated repeatedly with saline and 
given acute ethanol (1.0, 1.5, 2.0, or 2.5 g/kg) on day 11 displayed an equivalent 
locomotor response to the mice treated with acute ethanol on day 1 (data not shown). 
The data were presented as mean (+/- SEM).    
In order to determine whether the magnitude of sensitization to ethanol 2.5 g/kg 
differed in the adolescents and adults, the locomotor activity from day 11 was expressed 
as a percent increase from day 1 activity.  An unpaired t-test was used to compare the 
magnitude of sensitization between the age groups.  
In order to determine if degree of sensitization was influenced by acute response 
to ethanol, a linear regression analysis was conducted comparing locomotor response to 
acute ethanol (D1) versus the sensitization test day (D11) for two doses of ethanol (2.0 
and 2.5 g/kg) within each age group.  
Experiment 2a.  Sensitization: Time Course.  Groups of mice were evaluated for 
distance traveled (cm) following treatment with ethanol (2.0 or 2.5 g/kg) using four-way 
RM ANOVA, with age (adolescent and adult), ethanol dose, treatment duration (7 or 11 
days) and test day (acute and sensitization) as factors.  Significant interactions were 
followed with analysis by lower order (e.g., two-way) ANOVA where appropriate.  
Sensitization was defined as activity on day 7 or day 11 (D7 or D11) being significantly 
greater than activity on day 1 (D1).   
Experiment 2b. The mice treated with ethanol 2.0 g/kg for 15 days were analyzed 
using RM two-way ANOVA, with age (adolescent and adult) and treatment day (D1 or 
D15) as factors. Sensitization was defined as activity on day 15 being significantly 
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greater than activity on day 1 within an age group, as determined by post-hoc Tukey 
tests. The data were presented as mean (+/- SEM). 
Experiment 3.  Blood Ethanol Clearance.   The BEC data were analyzed using 3-
way RM ANOVA, with age (adolescent and adult), day (D1 and D11), and time (10, 60, 
and 180 minutes) post-ethanol injection as factors.  Significant interactions were 
followed with analysis by lower order (e.g., two-way) ANOVA in order to determine 
whether the BEC following acute ethanol and following chronic ethanol treatment was 
responsible for age-dependent differences in sensitization.  Post-hoc Tukey tests were 
used to extract group differences. 
 
RESULTS 
Basal Activity and Response to Acute Ethanol.  Since adolescent mice are 
differentially sensitive to acute effects of ethanol as compared to adults (Hefner and 
Holmes 2007), we first examined basal locomotor activity and response to acute ethanol 
(1.0 – 2.5 g/kg).  On the habituation days, no differences in locomotor activity were 
observed between the adolescent and adult groups (p=0.29; Adolescents: 3011 +/- 234 
cm; Adults: 2670 +/- 210 cm).  Adolescent and adult mice showed equal saline-induced 
locomotor activity but different locomotor response to acute ethanol treatment (Figure 4).  
Two-way ANOVA showed that adolescent mice were more sensitive to the acute 
locomotor activating effects of ethanol as compared to adults.  There was a significant 
main effect of age [F(1, 61)=11.01, p=0.002], a significant main effect of ethanol dose 
[F(4, 61)=10.05, p<0.001], and a significant interaction [F(4, 61)=3.02, p=0.024].  In the 
adolescents, ethanol doses of 1.5, 2.0, and 2.5 g/kg significantly increased locomotor 
activity (Figure 4).  Overall, these results indicate that adolescent DBA/2J mice are more 
sensitive than adult mice to the acute locomotor activating effects of ethanol in a dose-
dependent manner.   
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 Figure 4. Acute Locomotor Response to Ethanol. 
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Figure 4. Acute Locomotor Response to Ethanol.  DBA/2J adolescent (open bars) and 
adult (filled bars) locomotor response (distance traveled, cm, mean +/- SEM) to 
administration of ethanol (0 - 2.5 g/kg) during the 10-minute session.  * indicates 
significant increase in distance traveled compared to ethanol 0 g/kg, p<0.05.  + indicates 
significant increase in distance traveled compared to adult mice, p<0.05.   
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Sensitization: Dose Response.  Following acute ethanol treatment, adolescent and 
adult mice were tested for locomotor sensitization (ethanol 0 – 2.5 g/kg).  Locomotor 
sensitization was defined as a significant increase in locomotor activity on day 11 
compared to day 1 within each dose, as determined by post-hoc Tukey tests.  Three-
way ANOVA of age X ethanol dose X day revealed significant main effects of the 
between subject variables age [F(1, 56)=9.68; p=0.003] and ethanol dose [F(4, 
56)=48.81; p<0.001].  A significant main effect was also noted for the within subject 
factor day [F(1, 56)=148.43; p<0.001], along with a significant day X age interaction [F(1, 
56)=4.31; p<0.05], a significant day X dose interaction [F(4, 56)=38.32; p<0.001], and a 
significant day X age X dose interaction [F(4, 56)=5.88; p=0.001].  Due to the three-way 
interaction, locomotor activity was analyzed separately for adolescent and adult mice in 
order to examine age-dependent sensitization.  Overall, adolescent mice appeared to be 
less sensitive to ethanol sensitization as shown by lack of response to doses of ethanol 
that induced sensitization in adult mice (1.5 and 2.0 g/kg; Figure 4).  Within the 
adolescents, there was a significant main effect of dose [F(4, 29)=25.00, p<0.001], a 
significant main effect of treatment day [F(1, 29)=38.59, p<0.001], and a significant 
interaction [F(4, 29)=19.91, p<0.001].  Sensitization was only observed at the 2.5 g/kg 
ethanol dose (Figure 5A; p<0.001).  In the adults, there was also a significant main effect 
of dose [F(4, 28)=21.98, p<0.001], a significant main effect of treatment day [F(1, 
28)=129.89, p<0.001], and a significant interaction [F(4, 28)=17.88, p<0.001].  The 
adults showed sensitization at ethanol doses of 1.5, 2.0, and 2.5 g/kg (Figure 5B; 
ps<0.001).   These results indicate that the adolescent mice are less sensitive than the 
adult mice to ethanol sensitization, as they require a higher dose of ethanol (2.5 g/kg) to 
exhibit locomotor sensitization.    
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Figure 5. Ethanol Sensitization: Dose Response. 
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Figure 5. Ethanol Sensitization: Dose Response.  A. Adolescent mice locomotor 
response (distance traveled, cm, mean +/- SEM) during 10 minute test sessions on day 
1 and day 11 following administration of ethanol (0 – 2.5 g/kg).  * indicates significant 
increase in distance traveled on day 11 compared to day 1, p<0.05.  B. Adult mice 
locomotor response (distance traveled, cm, mean +/- SEM) during 10 minute test 
sessions on day 1 and day 11 following administration of ethanol (0 – 2.5 g/kg).  * 
indicates significant increase in distance traveled on day 11 compared to day 1, p<0.05.   
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In order to determine if the magnitude of sensitization to ethanol (2.5 g/kg) was 
greater in the adolescents than in the adults, the locomotor activity from day 11 was 
expressed as a percentage of the locomotor activity from day 1 (data not shown).  
Comparison of the adolescent and adult level of sensitization did not differ (p=0.53; 
Adolescents: 438.9 +/- 118 % increase; Adults: 357.3 +/- 48 % increase).  These data 
indicate that the adolescent and adult mice display sensitization to ethanol 2.5 g/kg to 
the same degree. 
 
Sensitization: Time Course.  In order to further assess age-dependent differences, we 
next examined the effect of different ethanol treatment durations on the induction of 
locomotor sensitization to ethanol (Figure 6).  Sensitization was defined as a significant 
increase in distance traveled on the final day of treatment (day 7 or 11) as compared to 
a single acute treatment (day 1).  The time course of the induction of ethanol 
sensitization was evaluated after ethanol (2.0 and 2.5 g/kg) tests in order to compare 
response to doses that demonstrated differential age-dependent sensitivity (shown in 
Figure 5).   
Four way ANOVA comparing age x dose x treatment duration x test day 
identified significant main effects for the between-subjects factors of age [F(1,54)=5.84; 
p=0.02] and ethanol dose [F(1,54)=15.89; p<0.001].  There was no main effect of 
treatment duration and no interactions between age, dose, and duration.  A significant 
main effect was also identified for the within-subject factor test day [F(1,54)=181; 
P=0.001].  Analysis of the two-way interactions showed that the main effect of test day 
(i.e., acute vs. sensitization test) was dependent on age [F(1,54)=9.44; p=0.003] and 
dose [F(1,54)=59.44; p<0.001].  Three-way interaction terms showed that the effect of 
test day (i.e., acute vs. sensitization test) was dependent on the level of age and dose 
[F(1,54)=12.9; p=0.001] as well as treatment duration and dose [F(1,54)=4.07; p<0.05].  
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Based on these significant interactions, the sensitization data was analyzed separately 
for each dose and duration. 
 For mice treated with ethanol (2.0 g/kg) for 7 days, two-way RM ANOVA 
revealed a significant main effect of test day [F(1, 31)=12.44; p=0.003] and a significant 
test day X age interaction [F(1, 31)=6.75; p=0.02].  Multiple comparisons showed that, 
overall, activity on day 7 was higher than activity on day 1 (p=0.004) and that this 
increase was dependent on an increase in locomotor activity in the adults on day 7 as 
compared to day 1 (p<0.001).   These data show that the adults show locomotor 
sensitization to ethanol (2.0 g/kg) after 7 days of treatment, while the adolescents do not 
show sensitization at this time point (Figure 6A).  For the 11 day time course of ethanol 
(2.0 g/kg), two-way RM ANOVA showed a significant main effect of test day [F(1, 
30)=8.32; p<0.02] and a significant test day X age interaction [F(1, 30)=26.46; p<0.001].  
Post-hoc comparisons showed that, overall, locomotor activity on day 11 was 
significantly greater than activity on day 1 (p<0.02), and this effect was caused by a 
significant increase in the adult group on day 11 compared to day 1 (p<0.001; Figure 
6A).  On day 1, the adolescents showed significantly more locomotor activity than the 
adults (p<0.001), while on day 11 the adults were more active than the adolescents 
(p<0.02).  These results indicate that the adult group displayed sensitization to ethanol 
(2.0 g/kg) following 11 days of treatment while the adolescent group did not show 
sensitization.  Furthermore, the adolescents displayed the expected greater acute 
locomotor activation to ethanol (2.0 g/kg), while the adults responded to a greater extent 
on the sensitization test day than the adolescents. 
 For ethanol (2.5 g/kg) after 7 days of treatment, two-way ANOVA showed only a 
significant main effect of day [F(1, 31)=78.15; p<0.001], indicating that all mice displayed 
significantly increased activity on day 7 compared to day 1 (p<0.001).  Similarly, ANOVA 
of treatment for 11 days with ethanol (2.5 g/kg) showed a significant main effect of day 
 24
[F(1, 30)=108.85; p<0.001], indicating that all mice displayed sensitization (Figure 6B).  
Taken together, these data show that regardless of duration of treatment, adolescent 
mice do not exhibit locomotor sensitization to ethanol (2.0 g/kg) while adult mice do 
exhibit sensitization to this dose of ethanol.  Both adolescent and adult mice display 
locomotor sensitization to ethanol (2.5 g/kg).  
 The time course was extended to 15 days for the ethanol (2.0 g/kg) in order to 
investigate whether treatment for a longer period of time would elicit sensitization in the 
adolescent group.  Two-way ANOVA revealed a significant main effect of age [F(1, 
12)=11.94; p=0.005], a significant main effect of test day [F(1, 27)=22.38; p<0.001], and 
a significant interaction [F(1, 27)=7.94; p<0.02].  Post-hoc Tukey tests showed no 
difference between day 15 and day 1 within the adolescents (p=0.23), while there was a 
significant increase in activity on day 15 in the adults (p<0.001).  These results indicate 
that the adolescent mice did not demonstration locomotor sensitization following 15 days 
of treatment with ethanol (2.0 g/kg), while the adult group did show sensitization.  On the 
acute test day 1, the adolescents were significantly more active than the adults 
(p<0.001), while the age groups were not different on day 15 (p=0.86; data not shown).   
 Overall, the time course experiment shows that adolescent mice do not display 
sensitization to ethanol (2.0 g/kg) with up to 15 days of ethanol exposure, while the adult 
mice show sensitization following only 7 days of exposure.  Both adolescent and adult 
mice exhibit sensitization to ethanol (2.5 g/kg) with only 7 days of exposure.  These 
results indicate that age-dependent ethanol sensitization is not effected by the duration 
of treatment but is mediated by the dose of ethanol. 
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Figure 6. Ethanol Sensitization: Time Course. 
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Figure 6. Ethanol Sensitization: Time Course.  A. Adolescent and adult locomotor 
response (distance traveled, cm, mean +/- SEM) following administration of ethanol 2.0 
g/kg during 10 minute test sessions on day 1 (acute test; open bars) and the final day (7 
or 11; sensitization test; filled bars).  * indicates significant increase in distance traveled 
compared to day 1, p<0.05.  B.  Adolescent and adult locomotor response (distance 
traveled, cm, mean +/- SEM) following administration of ethanol 2.5 g/kg during 10 
minute test sessions on day 1 (acute test; open bars) and the final day (7 or 11; 
sensitization test; filled bars).  * indicates significant increase in distance traveled 
compared to day 1, p<0.05.  † indicates an overall significant increase from acute test for 
the two ages combined, p<0.05.     
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Correlation: Acute X Sensitized Locomotor Response.  In order to examine the 
possibility that the acute locomotor response to ethanol was predictive of the degree of 
locomotor activation after repeated treatment, a linear regression comparing day 1 
(acute) activation and day 11 (sensitized) activation was performed in the adolescents 
and adults treated with either ethanol (2.0 or 2.5 g/kg).  There was no significant 
correlation between acute locomotor activation and sensitized locomotor activation in the 
adolescents or the adults at either ethanol dose (ps>0.1; data not shown).  These data 
indicate that the acute locomotor response to ethanol (2.0 or 2.5 g/kg) does not affect 
the magnitude of the sensitized locomotor response to repeated ethanol treatment in 
adolescent or adult mice.     
Blood Ethanol Concentration.   In order to examine whether differential age-
dependent sensitization might be mediated by differences in ethanol clearance, an 
analysis of blood ethanol concentration (BEC; mg/dL) was conducted for sensitization 
treatment with ethanol (2.0 g/kg).  Importantly, this dose represents an ethanol dose at 
which the adolescent mice did not develop sensitization while the adult mice developed 
sensitization.  The BEC was measured in adolescents and adults on day 1 (representing 
acute ethanol treatment) at 10, 60, and 180 minutes post-ethanol treatment.  The 10 
minute time point was examined to assess the BEC at a time point corresponding to the 
end of the locomotor behavior session, while the 60 and 180 minute time points were 
examined to assess the clearance of ethanol from the blood.  The BEC was also 
measured in adolescents and adults on day 11 (corresponding to the sensitization test 
day) in order to examine any groups differences in ethanol clearance after repeated 
ethanol treatment.  
The three-way RM ANOVA of BEC revealed a significant main effect of the 
between subject factor treatment day [F(1, 21)=40.88; p<0.001], a significant main effect 
of the within subject factor time post ethanol injection [F(2, 42)=586.47; p<0.001], a 
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significant time X age interaction [F(2, 42)=3.69; p<0.05], and a significant time X day 
interaction [F(2, 42)=12.32; p<0.001].  In order to assess whether differences in BEC on 
day 1 or day 11 were responsible for differences in locomotor activity of adolescents and 
adults, the BEC data were analyzed separately for day 1 and day 11. 
A two-way RM ANOVA of BEC on day 1 of ethanol (2.0 g/kg) treatment showed 
a main effect of age [F(1,6)=14.54; p=0.008], a main effect of time (minutes) post-
ethanol administration [F(2,12)=345.43; p<0.001], and a significant interaction 
[F(2,11)=15.09; p<0.001].  Within the adolescents and adults, the post-hoc Tukey test 
revealed that the BEC at 60 minutes was significantly less than the BEC at 10 minutes, 
while the BEC at 180 minutes was significantly less than the BEC at 60 minutes (Figure 
6A; ps<0.002).  These data are indicative of ethanol clearance from the blood.  Within 
the time points, the adolescents were significantly different than the adults only at 60 
minutes post-ethanol injection (p<0.001).  These data indicate that the adolescents had 
cleared more ethanol from the blood than the adults at 60 minutes after ethanol (2.0 
g/kg) administration on day 1.   
The two-way RM ANOVA on day 11 revealed no significant main effect of age 
[F(1,5)=0.08; p=0.79], a significant main effect of time post-ethanol injection 
[F(2,10)=184.06; p<0.001], and no significant interaction [F(2,10)=0.21; p=0.81].  For all 
mice, the BEC at 60 minutes was significantly less than the BEC at 10 minutes, while the 
BEC at 180 minutes was significantly less than the BEC at 60 minutes (Figure 6B; 
ps<0.005), indicating ethanol clearance from the blood over time.   
In order to examine the development of metabolic tolerance in the mice, the BEC 
at each time point was compared between day 1 and day 11.  The two-way ANOVA 
showed a significant main effect of day [F(1, 27)=50.25; p<0.001], a significant main 
effect of time [F(2, 49)=582.54; p<0.001], and a significant interaction [F(2, 49)=14.59; 
p<0.001].  Post-hoc Tukey tests indicated that the BEC at 10 and 60 minutes post 
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ethanol injection differed on day 1 and day 11 (ps<0.001).  This data is indicative of 
metabolic tolerance to ethanol following repeated administration of ethanol, which has 
been shown previously in adult and adolescent rats (Chester et al. 2005; Silvers et al. 
2003; Varlinskaya and Spear 2007). 
Overall, these data show that the adolescent mice clear more ethanol from the 
blood than adult mice following acute administration of ethanol (2.0 g/kg), but this effect 
diminishes following repeated administration of ethanol.  All of the mice show lower BEC 
to ethanol following repeated ethanol administration, indicating the development of 
metabolic tolerance.  Importantly, adolescent and adult mice have equivalent BEC at the 
10 minute time point, which corresponds to the time of the locomotor session during 
which the age groups display differential ethanol-induced locomotor activity. 
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Figure 7. Blood Ethanol Clearance. 
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Figure 7. Blood Ethanol Clearance.  A. BEC (mg/dL, mean +/- SEM) in adolescent and 
adult DBA/2J mice on day 1, 10, 60, and 180 minutes following administration of ethanol 
2.0 g/kg.  B.  BEC (mg/dL, mean +/- SEM) in adolescent and adult DBA/2J mice on day 
11, at 10, 60, and 180 minutes following administration of ethanol 2.0 g/kg.  * indicates 
significant difference between age groups, p<0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 30
DISCUSSION 
Adolescence is a time period marked by an increase in risk-taking behavior, which has 
been shown to lead to experimentation with drugs of abuse such as ethanol (Spear 
2000a).  The effects of ethanol on the maturing adolescent brain are not fully 
characterized at this time.  Studies have shown that adolescent rodents are more or less 
sensitive than adults to ethanol, depending on the behavior being measured.  It has 
been proposed that these differences in sensitivity might underlie the propensity for 
ethanol intake during adolescence to lead to alcoholism later in life (Spear and 
Varlinskaya 2005).  The present study extends the previous findings to ethanol 
locomotor sensitization and shows that adolescent DBA/2J mice are less sensitive than 
adult mice to ethanol-induced neurobehavioral adaptations. 
Adolescent DBA/2J mice showed an enhanced locomotor response to acute 
administration of ethanol 1.5 and 2.0 g/kg compared to the adults.  This is in agreement 
with a recent report in adolescent C57BL/6J mice that showed an increase in locomotor 
activity after 1.5 g/kg ethanol administration during the first 10 minutes of testing (Hefner 
and Holmes 2007).  These findings are significant because it has been shown in humans 
that heavy drinkers are more sensitive to the acute stimulant effects of ethanol than light 
drinkers (King et al. 2002).The acute activating effects of ethanol involve numerous 
neurotransmitter systems, including mesolimbic dopamine signaling, metabotropic and 
ionotropic glutamate receptors, GABA receptors, and opioid receptors (Blednov et al. 
2004; Demarest et al. 1998; Kalivas 1995; Meyer and Phillips 2003; Pastor et al. 2005; 
Vezina and Kim 1999).  The differences observed in the adolescent response to acute 
ethanol are possibly due to the fact that these neurotransmitter systems are not fully 
developed in the adolescent (Spear 2000a).  The undeveloped neurotransmitter systems 
of the adolescent mice could perhaps be similar to the neurotransmitter systems 
following sensitization in adult mice.  However, this explanation seems unlikely when it is 
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considered that the adolescents showed an enhanced acute response to ethanol 2.5 
g/kg while they also displayed sensitization to this dose.  
Repeated administration of ethanol in adult mice leads to an increase in 
locomotor activation that is markedly greater than the acute locomotor response, known 
as ethanol sensitization (Phillips et al. 1994).  It has been suggested that the neural 
adaptations which underlie locomotor sensitization might occur in the same brain regions 
which underlie drug reward and craving (Pierce and Kalivas 1997; Robinson and 
Berridge 1993; Vanderschuren and Kalivas 2000).  Interestingly, ethanol sensitization 
has not been studied in adolescents.  In the present study, the highest dose of ethanol 
(2.5 g/kg) tested was required to produce locomotor sensitization in the adolescent mice, 
while multiple ethanol doses (1.5, 2.0, 2.5 g/kg) produced locomotor sensitization in the 
adult mice.  Moreover, the time course study showed that even with a longer exposure 
time, the adolescent mice did not develop sensitization to ethanol (2.0 g/kg).  These 
results indicate that adolescent DBA/2J mice are less sensitive to ethanol-induced 
locomotor sensitization than adult mice.  The finding that adolescents are less sensitive 
to ethanol sensitization is significant because it has been shown in humans that sons of 
alcoholics, a group at high risk for developing alcoholism, are differentially sensitive to 
the physiological effects of ethanol when given repeated ethanol treatments (Newlin and 
Thomson 1991).  Perhaps blunted sensitivity to the neuroadaptations that occur during 
the induction of ethanol sensitization in adolescents may be one factor that contributes 
to the epidemiological observation that adolescent alcohol use is associated with 
increased risk of abuse in adulthood (Grant and Dawson 1998). 
One possible factor that could explain the difference in ethanol sensitization 
observed in this study is that the blood ethanol concentrations differ between the 
adolescent and adult groups.  For example, adolescent C57BL/6J mice show higher 
initial BEC than the adults following ethanol (3.0 g/kg) injection but significantly lower 
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BEC by 90 minutes post-injection, which suggests more rapid ethanol clearance in 
adolescent mice (Hefner and Holmes 2007). To address this possibility, we evaluated 
BEC in adolescent and adult mice following injection of the dose of ethanol (2.0 g/kg) 
that produced differential age-dependent locomotor sensitization.   The results show no 
differences in BEC between the age groups at the 10-minute time point either on day 1 
or on day 11.  This time point is critical because it corresponds to the length of the 
locomotor session during which the age-groups display differential locomotor activity, 
indicating dissociation between the BEC and locomotor activity. The results also extend 
previous findings in adolescent C57BL/6J mice and Sprague Dawley rats by showing 
that adolescent DBA/2J mice clear acute ethanol (2.0 g/kg) from the blood faster than 
adults at 60 minutes post-ethanol administration (Hefner and Holmes 2007; Little et al. 
1996).  On day 11 of the experiment, when adult mice show locomotor sensitization but 
adolescent mice do not, no differences in BEC between the age groups are apparent at 
any time point.  These data indicate dissociation between BEC and locomotor 
sensitization.  These data suggest that the age-dependent differential sensitization to 
ethanol (2.0 g/kg) observed in the present study cannot be attributed to differential BEC.     
Another possible explanation for the differential sensitization observed in 
adolescent mice in this study is that the increased acute response to ethanol (1.5 and 
2.0 g/kg) affected sensitization.  That is, the enhanced acute response on day 1 
prevented an increase in locomotor activity from occurring on day 11. However, previous 
studies have shown that both the neural mechanism and genetic correlates of acute 
locomotor activation are unrelated to those that underlie ethanol sensitization (Broadbent 
et al. 1995; Phillips et al. 1995).  Furthermore, no correlation between acute locomotor 
activity and sensitized locomotor activity was observed in the present study, indicating 
that the acute response on day 1 to ethanol was not predictive of the sensitized 
response on day 11.  The possibility also exists that the acute response to ethanol was 
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at the ceiling of locomotor activity, so that no further increase in activity could be 
observed following repeated ethanol administration.  This can be examined directly by 
observing the amount of time the animal was ambulatory in the chamber.  In this study, 
the adolescents were ambulatory on day 1 and day 11 for less than 5 minutes of the 
total 10 minutes that they were in the locomotor chamber (data not shown). This 
indicates that the ceiling of locomotor activity had not been reached during the session, 
as the mice had greater than 5 minutes to display enhanced locomotor activity.  
Together, these data confirm that the acute response to ethanol in the adolescents does 
not underlie their lack of ethanol sensitization.   
Previous studies have suggested that increased sensitivity to locomotor 
sensitization in adults is a marker for increased likelihood of drug dependence (Robinson 
and Berridge 1993).  One might predict, therefore, that adolescents would be more 
sensitive to ethanol sensitization based on human studies showing that ethanol intake 
during adolescence increases the likelihood of alcoholism in adulthood (Grant 1998).  
However, adolescent rodents are known to respond differently to ethanol than adults 
(see Introduction), which means predicted response patterns in adult rodents may not 
apply to adolescent rodents.  In the present study, adolescents were found to be less 
sensitive to ethanol sensitization, which corresponds to a previous study showing that 
adolescents were less sensitive to the sedative properties of ethanol (Silveri and Spear 
1998).  Interestingly, adolescents are more sensitive to ethanol’s inhibition of NMDA-
mediated excitation and long-term potentiation (Swartzwelder et al. 1995a; 1995b).  The 
NMDA receptor antagonist MK-801 has been shown to block ethanol sensitization at 
higher doses in DBA/2J adult mice (Broadbent and Weitemier 1999; Meyer and Phillips 
2003).  One possible explanation for the lack of ethanol sensitization seen in adolescent 
mice is that over the course of the development of sensitization, ethanol is more potently 
inhibiting the NMDA receptor, which effectively attenuates sensitization.  However, at the 
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higher ethanol dose of 2.5 g/kg, the adolescents develop sensitization, which makes this 
explanation unlikely. 
Overall, this is the first study to examine ethanol sensitization in adolescents, and 
the findings show that adolescent DBA/2J mice are less sensitive to ethanol sensitization 
than adult mice.  This effect is not due to the enhanced acute locomotor response to 
ethanol in the adolescents or to differences in BEC.  These data suggest that blunted 
sensitivity to ethanol-induced neurobehavioral adaptations during adolescence may be 
one factor that contributes to increased risk of abuse in adulthood. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III: MPEP INHIBITS THE INDUCTION OF ETHANOL SENSITIZATION IN 
ADULT, BUT NOT ADOLESCENT, DBA/2J MICE 
INTRODUCTION 
Adolescence is a critical developmental period during which alcohol or cocaine 
use in humans is often initiated (Johnston LD 2005).  It is known that people who start 
drinking during adolescence are four times more likely to become alcohol dependent as 
adults (Grant 1998). Animal studies have shown that adolescents and adults are 
differentially sensitive to the effects of many drugs of abuse, including ethanol and 
cocaine.  These differences in sensitivity occur in the absence of any differences in the 
brain availability of the drug, and instead seem to be related to an altered sensitivity of 
the neurobiological effects of the drugs (Spear 2000a; Spear and Brake 1983). 
Studies have shown that adolescent rodents are more sensitive to the effects of 
ethanol on measures of locomotor stimulation, anxiety, ataxia, spatial memory, 
conditioned place preference, and social interaction as compared to adult rodents 
(Hefner and Holmes 2007; Markwiese et al. 1998; Philpot et al. 2003; Rajendran and 
Spear 2004; Varlinskaya and Spear 2002; 2006; Yttri et al. 2004).  By contrast, 
adolescent rodents are less sensitive than adult rodents to the sedative and motor 
impairing effects of ethanol, to ethanol withdrawal induced anxiety, and analgesia 
(Doremus-Fitzwater and Spear 2007; Doremus et al. 2003; Hefner and Holmes 2007; 
Silveri and Spear 1998; Varlinskaya and Spear 2002; White et al. 2002).  These 
differences in the sensitivity of adolescents to ethanol are important because it has been 
shown that a decreased response to acute alcohol challenge during adolescence is a 
potent predictor of future alcoholism (Schuckit 1993; 1994). 
 
Similarly, studies assessing adolescent responses to cocaine have shown that 
adolescent rats are less sensitive than adults to cocaine induced locomotor stimulation 
but show the same cocaine-induced conditioned place preference (Campbell et al. 2000; 
Laviola et al. 1995).  Overall, adolescent rodents appear to be more or less sensitive to 
the effects of psychomotor stimulants, depending on which behavioral paradigm is 
tested (Frantz et al. 2007). 
One model of neurobehavioral adaptations that occur following chronic drug 
exposure is locomotor sensitization.  Sensitization is typically defined as a progressive 
increase in locomotor activity following repeated administration of a drug of abuse 
(Kalivas and Stewart 1991).  The process of sensitization is thought to produce enduring 
adaptive changes in brain and behavioral function that may underlie components of 
addiction (Kalivas et al. 1998; Robinson and Berridge 2000).  Research has shown that 
sensitization is mediated by an interconnected network of mesocorticolimbic brain 
regions (i.e., VTA, nucleus accumbens, prefrontal cortex, amygdala, and thalamus) and 
neurotransmitter systems (i.e., dopamine, glutamate, and GABA) (Kalivas 1995; Vezina 
and Kim 1999).  These brain regions and neurotransmitter systems all undergo 
alterations during the adolescent developmental period (Kalivas 1995; Spear 2000a; 
Vezina and Kim 1999).  Thus, sensitization models are useful tools to determine if 
adolescent vulnerability to addiction involves differential sensitivity to neurobehavioral 
changes that occur with repeated drug use.   
Recently, we have shown that adolescent DBA/2J mice are less sensitive to 
ethanol sensitization than adult mice (Stevenson et al. 2007).  Several studies of cocaine 
sensitization have shown that adolescent rodents display less, similar, or even greater 
cocaine-induced sensitization compared to adults, depending on the rat/mouse strain 
and injection procedure employed in the study (Camarini et al. 2007; Collins and 
Izenwasser 2002; Frantz et al. 2007; Laviola et al. 1995; Niculescu et al. 2005).  The 
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discrepancies in the results of these studies indicate that the maturation of the 
neurotransmitter systems involved in sensitization may differ between rat and mouse 
strains.  The present study was designed to evaluate the mechanism underlying 
sensitization to both ethanol and cocaine in adolescent and adult DBA/2J mice, a strain 
that has shown differential age-dependent sensitivity to both ethanol and cocaine 
sensitization (Camarini et al. 2007; Stevenson et al. 2007). 
Evidence indicates that glutamate signaling is an important component of both 
ethanol and cocaine sensitization in adult animals (Broadbent et al. 2003; Broadbent and 
Weitemier 1999; Kotlinska et al. 2006; Vanderschuren and Kalivas 2000).  Metabotropic 
glutamate receptors (mGluRs) are a class of G-protein coupled glutamate receptors. The 
group I mGluR, mGluR5, is expressed abundantly in the nucleus accumbens and ventral 
tegmental area, brain regions which are known to be involved in locomotor sensitization 
(Kalivas 1995; Romano et al. 1996; Vezina and Kim 1999).   
Ethanol has been shown to inhibit mGluR5 function in Xenopus oocytes (Minami 
et al. 1998), while behavioral studies have shown that antagonism of mGluR5 reduces 
ethanol self-administration and blocks the discriminative stimulus properties of ethanol 
(Backstrom et al. 2004; Besheer and Hodge 2004; Olive et al. 2005; Schroeder et al. 
2005).  It has recently been shown that the mGluR5 antagonist, MTEP, inhibits the 
expression of ethanol sensitization in adult mice (Kotlinska et al. 2006).  However, the 
role of mGluR5 in the induction of ethanol sensitization has not been studied in 
adolescent or adult mice. 
Evidence indicates that mGluR5 is involved in many of the behavioral effects of 
cocaine.  The mGluR5 knockout mice lack cocaine-induced locomotor stimulation and 
the mGluR5 antagonist MPEP blocks acute cocaine-induced locomotor stimulation 
(Chiamulera et al. 2001; Herzig and Schmidt 2004; McGeehan et al. 2004).  
Furthermore, mGluR5 antagonism attenuates cue-induced cocaine seeking, cocaine 
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self-administration, and the conditioned rewarding effects of cocaine (Backstrom and 
Hyytia 2006; Kenny et al. 2005; McGeehan and Olive 2003).  By contrast, recent 
evidence indicates that the mGluR5 antagonist MTEP does not alter the expression of 
cocaine sensitization in adult rats (Dravolina et al. 2006).  The role of mGluR5 in 
adolescent cocaine sensitization remains unexplored. 
Although it has been shown that glutamate receptors, along with GABA and 
dopamine receptors, are involved in ethanol sensitization, little is known about the 
intracellular molecular events that take place to bring about the long term changes 
associated with locomotor sensitization (Broadbent and Harless 1999; Broadbent et al. 
2005).  Activation of group I mGluR’s is known to upregulate phosphorylation of the MAP 
kinase ERK1/2 (Choe and Wang 2001a; 2001b).  Evidence is emerging that the activity of 
the ERK1/2 is modulated in reward-associated brain regions in response to drugs of 
abuse, including ethanol (Berhow et al. 1996; Kalluri and Ticku 2002; Tsuji et al. 2003; 
Valjent et al. 2000; Valjent et al. 2004).  The ERK1/2 pathway is activated when 
phosphorylated by MEK1/2, which causes ERK1/2 to phosphorylate gene transcription 
factors such as CREB and Elk-1.  The regulation of gene transcription by the ERK1/2 
allows it to mediate long-term changes in behavioral functions (Grewal et al. 1999; Qi 
and Elion 2005; Sweatt 2004; Thomas and Huganir 2004; Wang et al. 2007).  The ability 
of ERK1/2 to modulate long-term neurobiological changes in response to drug 
administration makes it an intriguing molecular target for the induction of locomotor 
sensitization.  In fact, recent evidence shows that an inhibitor of the ERK pathway, 
SL327, inhibits the induction of cocaine and amphetamine sensitization (Valjent et al. 
2006).  Although it is known that chronic exposure to ethanol vapor reduces ERK1/2 
phosphorylation, the effect of ethanol sensitization on phophorylated ERK1/2 has not 
been studied (Sanna et al. 2002). 
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The present study was designed to examine the role of mGluR5 in the induction 
of ethanol and cocaine sensitization in adolescent and adult DBA2/J mice using the 
receptor antagonist MPEP.  The role of the downstream signaling kinase ERK1/2 in the 
induction of ethanol sensitization was examined using immunohistochemistry. 
 
MATERIALS AND METHODS 
Animals.  Male 3-week old (adolescent) and 8-week old (adult) DBA/2J mice 
(Jackson Laboratories, Bar Harbor, ME) were housed in groups (4 animals per cage) in 
standard Plexiglas cages with food (Purina Rodent Chow) and water available ad 
libitum.  The colony was maintained at 27oC on a 12-hour light/dark cycle, with the lights 
on at 10pm.  The behavioral experiments were conducted during the dark portion of the 
cycle.  Mice were handled and weighed daily for 1-week prior to, and for the duration of, 
the experiment.  Animals were under continuous care and monitoring by the Division of 
Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were carried out in 
accordance with the NIH Guide to Care and Use of Laboratory Animals (National 
Research Council, 1996) and institutional guidelines. 
 Behavioral Apparatus.  The locomotor activity (horizontal distance traveled, cm) 
of adolescent and adult mice was measured in eight covered Plexiglas chambers (30 
cm2, Med Associates, Georgia, VT).  Two sets of 16 pulse-modulated infrared 
photobeams were located on opposite walls to record ambulatory movements in the X-Y 
(horizontal) plane.  All software settings were the same for adults and adolescent mice.  
The activity chambers were computer-interfaced (Med Associates) for data sampling at 
100-millisecond resolution.   
Experimental Procedures.  Mice were adapted to the colony and to handling for 
1-week (adolescents=P28; adults=P63).  On locomotor testing days, mice were taken in 
the home cage to the testing room at least 30-minutes prior to the session to habituate to 
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the testing room.  The first two days of the each experiment were habituation days (H1 
and H2).  On these days, all mice received a pretreatment intraperitoneal (IP) injection of 
saline and were placed back into their home cages.  Thirty minutes after the 
pretreatment injection, mice were given an IP injection of saline and were immediately 
placed in the locomotor chamber for the 10 minute session.   
Experiment 1: Effect of MPEP on Ethanol Sensitization.  On day 1, adolescent 
and adult mice were given a pretreatment injection of saline and returned to their home 
cages.  Thirty minutes later, mice were injected with ethanol (0, 2.0, or 2.5 g/kg) and 
immediately placed in the locomotor chamber for 10 minutes (n=8 per age group per 
pretreatment per ethanol dose).   
On days 2-10, mice were given a pretreatment injection of MPEP (0 or 30 mg/kg) 
30-minutes prior to an injection of ethanol (0, 2.5, or 3.0 g/kg) in the home cage.  No 
locomotor testing was performed on these days. 
On day 11, mice were given a pretreatment injection of saline and returned to the 
home cage.  Thirty minutes later, mice were injected with ethanol (0, 2.0, or 2.5 g/kg) 
and were immediately placed into the locomotor chamber to be tested for locomotor 
sensitization.     
Experiment 2: MPEP Dose Response.  On day 1, adult mice were given a 
pretreatment injection of saline and returned to their home cages.  Thirty minutes later, 
mice were injected with ethanol (2.0 g/kg) and immediately placed in the locomotor 
chamber for 10 minutes (n=8 per MPEP dose).   
On days 2-10, mice were given a pretreatment injection of MPEP (0, 1, 10, or 30 
mg/kg) 30-minutes prior to an injection of ethanol (2.5 g/kg) in the home cage.  No 
locomotor testing was performed on these days. 
 41
On day 11, mice were given a pretreatment injection of saline and returned to the 
home cage.  Thirty minutes later, mice were injected with ethanol (2.0 g/kg) and were 
immediately placed into the locomotor chamber to be tested for locomotor sensitization.     
Experiment 3: Immunohistochemical Analysis – pERK1/2.  Following the locomotor 
test session on day 11, all mice in experiment 1 (see Table 1: Experimental Design) 
were deeply anesthetized with pentobarbital (100 mg/kg IP) and transcardially perfused 
with 0.1 M phosphate buffered saline (PBS; pH 7.4) followed by 4% paraformaldehyde. 
The skulls were postfixed overnight, and then rinsed and stored in PBS at 4°C. Brains 
were sectioned at 40 µm and stored (-20°C) in cryoprotectant until 
immunohistochemistry processing.  
For immunohistochemistry, the tissue was washed in PBS, the endogenous 
peroxidase activity was blocked in 0.6% H2O2, and antigen retrieval was performed at 
70°C for 30 min (Antigen Retrieval Citra, BioGenex).  Sections were blocked in 
PBS/0.1%triton-x/4% horse serum for 30 minutes and incubated at +4°C overnight in 
primary polyclonal antibody to p-ERK1/2 (1:400; Cell Signaling Technology, Inc, Danvers, 
MA). The following day, sections were washed in PBS and incubated in secondary 
antibody for one hour (Dako EnVision Kit, Dako).  Immunoreactivity was detected with 
nickel-enhanced diaminobenzidine (Dako EnVision Kit) as a chromagen.  Sections were 
counterstained with toluidine blue, mounted, dried and coverslipped with Cytoseal.  For 
consistency of staining across subjects, brain tissue from all groups was processed 
simultaneously. 
Immunoreactivity was quantified using Bioquant image analysis software (Bioquant 
Nova Advanced Image Analysis; R&M Biometric, Nashville, TN).  The image was 
background corrected and normalized to preset light levels to ensure consistent data 
collection.  Cell count measurements were calculated from a brain region and divided by 
the area of the region and expressed as cells/mm2.  For the dentate gyrus, cells were 
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counted manually and expressed as the average number of cells/dentate.  All data was 
acquired by a researcher blind to group condition from 4 sections/brain region/animal 
and averaged to obtain a single value per subject. 
TABLE 1: Experimental Design 
 
 
Day Hab 1 & 2 1 2 - 10 11 
Location Locomotor Chamber Locomotor Chamber Homecage Locomotor Chamber
Saline Saline Saline Saline/ Saline Saline 
MPEP30 Saline Saline MPEP 30mg/kg / Saline Saline 
Acute E2 Saline Saline Saline/ Saline Ethanol 2.0 g/kg 
Acute E2.5 Saline Saline Saline/ Saline Ethanol 2.5 g/kg 
Chronic E2 Saline Ethanol 2.0 g/kg Saline/ Ethanol 2.5 g/kg Ethanol 2.0 g/kg 
MPEP/ E2 Saline Ethanol 2.0 g/kg MPEP 30mg/kg / Ethanol 2.5 g/kg Ethanol 2.0 g/kg 
Chronic E2.5 Saline Ethanol 2.5 g/kg Saline/ Ethanol 3.0 g/kg Ethanol 2.5 g/kg 
MPEP/ E2.5 Saline Ethanol 2.5 g/kg MPEP 30mg/kg / Ethanol 3.0 g/kg Ethanol 2.5 g/kg 
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 Experiment 4: Effect of MPEP on Cocaine Sensitization.  Mice were allowed to 
habituate to the locomotor chambers during two 1-hour sessions (Habituation days 1 
and 2).  In both the adolescent and adult mice, total distance traveled on the second 
habituation session did not differ among groups.  The initiation of cocaine sensitization 
was measured every other day, for a total of 5 cocaine exposures over 9 days.  On 
these days (Cocaine days 1-5), mice were pretreated with MPEP (0, 10, or 30 mg/kg, IP) 
and returned to the home cage.  30-minutes later, mice were given an injection of saline 
or cocaine (10 mg/kg, IP) and immediately placed in the locomotor chamber for 1 h.  24 
hours following the fifth cocaine exposure, mice were tested for the expression of 
cocaine sensitization.  On this day (Catania et al.), mice were given an injection of saline 
30 minutes prior to an injection of cocaine (10 mg/kg, IP), and placed in the locomotor 
chamber for 1 h. 
Drugs.  Ethanol (95% w/v) was diluted in saline (0.9%) to a concentration of 20% 
(v/v) and injected (IP) at different volumes to achieve the appropriate dosage (i.e., 2.0 
and 2.5 g/kg). Cocaine hydrochloride (Sigma-Aldrich) was dissolved in 0.9% saline.  The 
mGluR5 antagonist MPEP [2-methyl-6-(phenylethynyl)-pyridine] was dissolved in 0.9% 
saline.  Cocaine and MPEP were injected IP at a volume of 10 mL/kg.   
Behavioral Measures and Data Analysis.  Horizontal distance traveled (in 
centimeters) during the 10-minute session was calculated from the number of 
photobeam breaks and presented as mean ± SEM.  Statistical significance was defined 
as p≤0.05 in all experiments.      
Experiment 1: Effect of MPEP on Ethanol Sensitization.  Distance traveled (cm) 
was analyzed separately for adolescents and adults at each ethanol dose (0, 2.0, or 2.5 
g/kg) using three-way RM ANOVA of the between groups factors pretreatment (MPEP 0 
or 30 mg/kg) and ethanol treatment (0 or 2.0 g/kg) and the within group factor 
sensitization (locomotor activity on day 1 vs day 11).  Significant interactions were 
 44
followed with lower order (e.g. two-way) ANOVA where appropriate.  Sensitization was 
defined as activity on day 11 being significantly greater than activity on day 1 within an 
ethanol dose, as determined by post-hoc Tukey tests. This within group definition of 
sensitization was applied because it was observed that groups of adolescent and adult 
mice treated repeatedly with saline and given acute ethanol (2.0 or 2.5 g/kg) on day 11 
displayed an equivalent locomotor response to the mice treated with acute ethanol on 
day 1 (data not shown). The data were presented as mean (+/- SEM).    
Experiment 2: MPEP Dose Response.  Distance traveled (cm) on sensitization 
test day 11 was analyzed using one-way ANOVA, with MPEP dose (0, 1, 10, or 30) as 
the factor.  Post-hoc Tukey’s test was used to determine between group differences.  
The data were presented as mean (+/- SEM).  
Experiment 3: Immunohistochemical Analysis - pERK1/2.   Data were presented 
as the average cells/mm2 within adolescents and adults at each ethanol dose, and 
analyzed using one-way ANOVA for each age group. 
Experiment 4: Effect of MPEP on Cocaine Sensitization.  Locomotor activity was 
determined by the total distance traveled (cm).  In order to correspond with maximal 
receptor occupancy after IP injection of MPEP in mice (Anderson et al. 2003), locomotor 
activity during the first 15 min of the session was analyzed and presented.  Open field 
activity was determined by the ratio of distance traveled in the center of the open field to 
total distance traveled in the 15-min interval.  Acquisition of sensitization and open field 
activity were analyzed using two-way repeated measures analysis of variance (RM 
ANOVA), with one factor repetition (treatment day).  Tukey post hoc tests were used to 
extract significant main effects. Sensitization was defined as significantly greater activity 
on day 5 relative to day 1.  The magnitude of sensitization was determined by the 
difference of total activity on Day 5 from Day 1, and analyzed using one-way ANOVA.  
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Activity on the Test Day was analyzed using one-way ANOVA.  Statistical significance 
was declared at p≤0.05. 
 
RESULTS 
Effect of MPEP on Ethanol Sensitization.  It has been shown previously that the 
mGluR5 antagonist MTEP blocks the expression of ethanol sensitization (Kotlinska et al. 
2006).  In order to determine the role of mGlu5 receptor in the induction of ethanol 
sensitization, another mGluR5 antagonist, MPEP, was used in both adolescent and adult 
DBA/2J mice at ethanol doses (2.0 and 2.5 g/kg) for which the two age groups have 
been shown to display differential ethanol sensitization (Stevenson et al. 2007).  
Locomotor sensitization was defined as a significant increase in distance traveled on day 
11 compared to the acute response on day 1.  MPEP was given on the intervening days 
(2-10) 30 minutes before ethanol (0, 2.5, or 3.0 g/kg), during the induction phase of 
ethanol sensitization (Figure 8).   
In the adolescents treated with ethanol (2.0 g/kg), three-way RM ANOVA of the 
between subject factors pretreatment (MPEP 0 or 30 mg/kg) and ethanol treatment (0 or 
2.0 g/kg) and the within subject factor sensitization (day 1 vs day 11) revealed only a 
significant effect of ethanol treatment [F(1, 23)=190.67; p<0.001].  This result indicates 
that ethanol caused a significant increase in locomotor activity but did not lead to 
sensitization (Figure 8A).  For ethanol (2.5 g/kg), a dose at which adolescents do display 
ethanol sensitization (Stevenson et al. 2007), the three-way RM ANOVA again revealed 
a significant between subject main effect of ethanol treatment [F(1, 22)=163.86; 
p<0.001], a significant main effect of the within subject factor sensitization [F(1, 
22)=111.87; p<0.001], and a significant sensitization X ethanol treatment interaction 
[F(1, 22)=105.08; p<0.001]. These results indicated that all mice treated with ethanol 
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were more active on day 11 than on day 1 and that MPEP did not alter locomotor activity 
(Figure 8B). 
In the adults treated with ethanol (2.0 g/kg), three-way RM ANOVA revealed a 
significant between subject main effect of pretreatment [F(1, 24)=4.46; p<0.05], a 
significant between subject main effect of ethanol treatment [F(1, 24)=69.99; p<0.001], 
and significant within subject effects of sensitization [F(1, 24)=35.52; p<0.001], 
sensitization X pretreatment [F(1, 24)=6.77; p<0.02], and sensitization X ethanol 
treatment [F(1, 24)=30.11; p<0.001].   Follow-up two-way RM ANOVA of the ethanol 
treated group showed a significant main effect of treatment day [F(1, 12)=35.14; 
p<0.001] and a significant day X MPEP pretreatment interaction [F(1, 12)=5.06; p=0.04].  
In the control animals receiving saline pretreatment, activity on day 11 was significantly 
greater than activity on day 1 (p<0.001).  In the group receiving MPEP (30 mg/kg) 
pretreatment, activity on day 11 was also significantly greater than activity on day 1 
(p=0.02).  On day 11, the control group was significantly more active than the MPEP 
treated group (p<0.01).  Together, these data indicate that MPEP treatment significantly 
blunted the sensitization response on day 11 (Figure 8C).   
In the adults at the ethanol (2.5 g/kg) dose, three-way RM ANOVA revealed 
significant main effects of the between subject factors pretreatment [F(1, 25)=5.85; 
p<0.03], ethanol treatment [F(1, 25)=133.12; p<0.001], and pretreatment X ethanol 
treatment [F(1, 25)=4.35; p<0.05], and significant main effects of the within subject 
factors sensitization [F(1, 25)=118.65; p<0.001], sensitization X pretreatment [F(1, 
25)=9.99; p<0.01], sensitization X treatment [F(1, 25)=96.86; p<0.001], and sensitization 
X pretreatment X treatment [F(1, 25)=8.47; p<0.01].  Follow-up two-way RM ANOVA of 
the ethanol treated group showed a significant main effect of pretreatment [F(1, 
12)=5.35; p=0.039], a significant main effect of day [F(1, 12)=109.41; p<0.001], and a 
significant interaction [F(1, 12)=9.38; p=0.01].  In both the control and MPEP pretreated 
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groups, activity on day 11 was significantly greater than activity on day 1 (p<0.001).  On 
day 11, the control group was significantly more active than the MPEP group (p=0.001).  
Mice that received ethanol 0 g/kg throughout the experiment showed no differences on 
day 1 and day 11, and MPEP treatment in this group had no effect on locomotor 
behavior.  These data show that pretreatment with MPEP (30 mg/kg) significantly blunts 
the induction of ethanol sensitization (Figure 8D).  This effect is only present in the adult 
mice and occurs for ethanol (2.0 and 2.5 g/kg) sensitization.   
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Figure 8. MPEP Blunts Ethanol Sensitization in Adults only. 
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Figure 8. MPEP blunts ethanol sensitization in adult DBA/2J mice only. A. Distance 
traveled (cm, +/- SEM) during the 10-minute locomotor session in adolescent DBA/2J 
mice treated with ethanol 0 or 2.0 g/kg on day 1 and day 11. Groups were pretreated 
with MPEP (0 or 30 mg/kg) 30-minutes before ethanol 0 or 2.5 g/kg on days 2-10 in the 
homecage.  B. Distance traveled (cm, +/- SEM) during the 10-minute locomotor session 
in adolescent DBA/2J mice treated with ethanol 0 or 2.5 g/kg on day 1 and day 11. 
Groups were pretreated with MPEP (0 or 30 mg/kg) 30-minutes before ethanol 0 or 3.0 
g/kg on days 2-10 in the homecage.  C. Distance traveled (cm, +/- SEM) during the 10-
minute locomotor session in adult DBA/2J mice treated with ethanol 0 or 2.0 g/kg on day 
1 and day 11. Groups were pretreated with MPEP (0 or 30 mg/kg) 30-minutes before 
ethanol 0 or 2.5 g/kg on days 2-10 in the homecage.  *=significantly different than the 
saline/ethanol group, p<0.05.  D. Distance traveled (cm, +/- SEM) during the 10-minute 
locomotor session in adult DBA/2J mice treated with ethanol 0 or 2.5 g/kg on day 1 and 
day 11. Groups were pretreated with MPEP (0 or 30 mg/kg) 30-minutes before ethanol 0 
or 3.0 g/kg on days 2-10 in the homecage.  *=significantly different than the 
saline/ethanol group, p<0.05.   
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MPEP Dose Response.   In order to determine the dose response curve for 
MPEP’s blunting of ethanol sensitization, adults were given pretreatment with MPEP 
doses of 0, 1, 10, and 30 mg/kg and treated for sensitization to ethanol (2.0 g/kg; Figure 
9).  The one-way ANOVA of locomotor activity on day 11 showed a significant between 
group difference [F(3, 27)=5.31; p=0.005].  Post-hoc analysis showed that the group 
treated with MPEP (30 mg/kg) was significantly less active than the groups treated with 
MPEP (0 and 1 mg/kg; p<0.04).  These results indicate that pretreatment with only 
MPEP 30 mg/kg significantly blunts the sensitized locomotor response on day 11, while 
MPEP (1 and 10 mg/kg) do not significantly alter ethanol sensitization.   
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Figure 9. MPEP Dose Response on Sensitization Test Day 11. 
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Figure 9. MPEP dose-dependently blunts ethanol sensitization in adult DBA/2J mice. 
Distance traveled (cm, +/- SEM) in adult DBA/2J on test day 11.  Mice were treated with 
ethanol 2.0 g/kg on day 1, followed by treatment with MPEP 0, 1, 10 or 30 mg/kg and 
ethanol 2.5 g/kg on days 2-10.  When tested on day 11 with ethanol 2.0 g/kg, there was 
a significant difference between the saline/ethanol group and the MPEP 30/ethanol 
group, *=p<0.05. 
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Immunohistochemical Analysis – pERK1/2.  To determine a potential mechanism 
underlying the induction of ethanol sensitization and the blockade of sensitization by the 
mGluR5 antagonist MPEP, an analysis of the phosphorylated (i.e., activated) form of 
ERK1/2 was conducted using immunohistochemistry (Summarized in Table 2).  Analysis 
of the adolescent mice showed that acute ethanol (2.0 and 2.5 g/kg) significantly 
increased the number of pERK1/2 positive cells in the central amygdala [F(7, 48)=17.98; 
p<0.001], as compared to all other treatment groups (Figure 10A & B; p<0.04).  
However, tolerance to this effect was observed in the mice treated chronically with 
ethanol (sensitization group), as this group did not differ from saline controls (p>0.97).  
The only other significant difference between groups was in the dentate gyrus of the 
hippocampus [F(7, 51]=8.41; p<0.001].  Mice treated with acute ethanol (2.0 and 2.5 
g/kg), chronic ethanol (2.0 and 2.5 g/kg), and MPEP (30 mg/kg) with ethanol (2.0 or 2.5 
g/kg) all had significantly less pERK1/2 than the saline control group (Figure 11A & B; 
p<0.05).  No significant changes in pERK1/2 were found in the other brain regions 
examined (Table 2).   
In the adults, similar effects were found between groups in the central amygdala 
[F(7, 54)=22.3; p<0.001] and in the dentate gyrus [F(7, 53)=19.4; p<0.001].  As in the 
adolescents, acute ethanol (2.0 and 2.5 g/kg) significantly increased pERK1/2 in the 
central amygdala compared to all other groups (Figure 10C & D; p<0.001), while acute 
and chronic ethanol (2.0 and 2.5 g/kg) significantly inhibited pERK1/2 in the dentate gyrus 
compared to the saline and MPEP control groups (Figure 11C & D; p<0.02).  Also, 
significant between group differences were found for the nucleus accumbens shell [F(7, 
49)=2.26; p<0.05], the lateral septum [F(7, 51)=2.47; p<0.03], and the lateral habenulum 
[F(7, 54)=3.28; p=0.006].  The group treated with chronic ethanol (2.0 g/kg) showed a 
significant increase in pERK1/2 positive cells in the nucleus accumbens shell (Figure 
12C; p<0.02) and a significant decrease in the lateral habenulum (p=0.01).  Overall, 
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these results showed that ethanol treatment altered the number of pERK1/2 positive cells 
in certain brain regions, but there is no link between ethanol sensitization and pERK1/2 in 
the adolescent or adult mice.  That is, pERK1/2 does not consistently change in groups 
that sensitize (adolescent ethanol (2.5 g/kg) and adult ethanol (2.0 and 2.5 g/kg)) 
compared to groups that do not sensitize (adolescent ethanol (2.0 g/kg)). 
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 Figure 10. PERK1/2 in the Central Amygdala. 
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Figure 10.  pERK1/2 expression in the Central Amygdala is increased by acute ethanol 
treatment.  In the adolescents and adults, pERK1/2 expression is increased by acute 
ethanol (2.0 or 2.5 g/kg).  This effect is absent following treatment with chronic ethanol 
(2.0 or 2.5 g/kg).  Photos are representative samples from the groups.  *=Significantly 
different than saline, p<0.05. 
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Figure 11. PERK1/2 in the Dentate Gyrus. 
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Figure 11.  pERK1/2 expression in the Dentate Gyrus is decreased by both acute and 
chronic ethanol treatment.  In the adolescents and adults, pERK1/2 expression is 
reduced by acute and chronic ethanol (2.0 or 2.5 g/kg).  In the adults, chronic treatment 
with ethanol (2.5 g/kg) produces tolerance to the acute ethanol induced reduction in 
pERK1/2.  Treatment with chronic MPEP (30 mg/kg) and ethanol (2.0 or 2.5 g/kg) does 
not alter the reduced expression of pERK1/2 caused by ethanol treatment alone.  
Photos are representative samples from the groups.  *=Significantly different than 
saline, p<0.05.  +=Significantly different than acute ethanol, p<0.05. 
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Figure 12. PERK1/2 in the Nucleus Accumbens Shell. 
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Figure 12.  pERK1/2 is increased in the Nucleus Accumbens shell in an age and dose 
dependent manner.  pERK1/2 is increased in the adult mice treated with chronic ethanol 
(2.0 g/kg) only.  pERK1/2 expression returns to baseline levels following Inhibition of 
ethanol sensitization with MPEP (30 mg/kg). The ethanol 2.5 g/kg dose does not effect 
pERK1/2 expression.  In the adolescents, pERK1/2 expression does not change due to 
any treatment with ethanol or MPEP.  *=Significantly different compared to saline treated 
group, p<0.05. 
 
 
 
 
 
 
 
 
TABLE 2: PERK1/2 Immunohistochemistry Across the Brain. 
Adolescent      
EtOH 2 
g/kg     
EtOH 2.5 
g/kg   
Brain Regions Saline MPEP 
Acute 
EtOH 
Sens 
EtOH MPEP/EtOH 
Acute 
EtOH 
Sens 
EtOH MPEP/EtOH 
Nuc. Accumbens                 
  Shell  
757.4+/-
153.7 
1022.8+/-
65 
1057.3+/-
99.8 
983.9+/-
142.9 
1101.4+/-
143.2 
920.2+/-
149.1 
848.8+/-
150.9 
882.8+/-
85.5 
  Core  
664.8+/-
81.3 
930.3+/-
42.1 
820.8+/-
62.1 
634.6+/-
114 
832.7+/-
76.6 
509.8+/-
99.3 
540.5+/-
79.6 
529.4+/-
68.7 
Prefrontal Cortex                 
  Medial  
329.9+/-
36.9 
285.4+/-
57.8 
308.6+/-
88.1 
335+/-
94.2 
276.3+/-
49.7 
490.5+/-
39.6 
324.3+/-
55.4 304+/-52 
Amygdala                  
  Central  
405.5+/-
106.1 
132.9+/-
29.7 
1545.4+/-
220.2* 
449.9+/-
128.8 
519.7+/-
100.9 
2137.2+/-
175.8* 
631.9+/-
206.5 
807.8+/-
169.5 
  Basolateral 
171.3+/-
44 
110.7+/-
38 
150.7+/-
68.1 
122+/-
32.8 83.5+/-23.5 
207.5+/-
51 
222.1+/-
51.4 
185.2+/-
26.1 
Hippocampus                  
  Dentate Gyrus 
19.1+/-
1.9 
16.1+/-
0.9 
11.4+/-
1.1* 
11.2+/-
1.3* 12.6+/-2.6 
6.6+/-
0.8* 
9.3+/-
0.8* 11.1+/-1.1* 
Thalamus                  
  PVN  
1080.8+/-
53.4 
782.8+/-
67.8 
1247.8+/-
138.3 
894.1+/-
139.4 
927.1+/-
165.2 
1428+/-
124.8 
1238.2+/-
84.6 
1257.7+/-
93.6 
Hypothalamus                  
  PVN  
2138.6+/-
227.4 
1942+/-
169.2 
2031.5+/-
152.6 
1677+/-
167.5 
1884.8+/-
206.4 
2228+/-
182.2 
1879.7+/-
174 
2132.7+/-
244.4 
Lateral Septum 
1234.1+/-
201.7 
572.6+/-
183.3 
759+/-
182.9 
578.6+/-
204.6 
501.5+/-
180.6 
962.3+/-
250.1 
936.1+/-
230.2 
723.9+/-
161.3 
Lateral Habenula 
1757.2+/-
272.4 
872+/-
148.3 
1082.2+/-
297.2 
964.3+/-
241.9 
791.4+/-
167.6 
1304.2+/-
187.1 
1158.3+/-
149.9 
1577+/-
268.4 
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TABLE 2: Continued. 
 
Adult       
EtOH 2 
g/kg     EtOH 2.5 g/kg 
Brain Regions Saline MPEP 
Acute 
EtOH 
Sens 
EtOH MPEP/EtOH 
Acute 
EtOH 
Sens 
EtOH MPEP/EtOH 
Nuc. Accumbens                 
  Shell  
508.2+/-
81.1 
805.6+/-
100.1 
832.7+/-
179 
1188.8+/-
97.5* 
905.4+/-
128.1 
622.7+/-
138.4 
777.3+/-
124.6 801+/-182.4 
  Core  
482.9+/-
90.5 
640.5+/-
83.3 
546.3+/-
133.3 
814.8+/-
74.5 
723.4+/-
90.5 
348.7+/-
89.9 
451.8+/-
46.1 
583.8+/-
95.2 
Prefrontal Cortex                 
  Medial  
338.7+/-
58 
422.3+/-
94 
376.7+/-
32.6 
426.6+/-
65.6 
332.5+/-
24.6 
497.7+/-
22.1 
373.7+/-
57 
341.3+/-
36.7 
Amygdala                  
  Central  
701.1+/-
209 
302.7+/-
86.3 
1624.8+/-
149.2* 
228.7+/-
34.3 
311.4+/-
109.2 
1964.3+/-
113.6* 
509.7+/-
189.3 
702.2+/-
139.8 
  Basolateral 
277.6+/-
54.5 
258.4+/-
55.9 
290+/-
114.5 
200.9+/-
100.8 
158.9+/-
42.2 
179.1+/-
32.8 206+/-45 233+/-63.6 
Hippocampus                  
  
Dentate 
Gyrus 
16.9+/-
2.3 
15.8+/-
1.5 
4.9+/-
0.5* 10+/-1.3* 8.3+/-0.7* 2+/-0.4* 
7.8+/-
1.1*# 5.2+/-0.5* 
Thalamus                  
  PVN  
1299.9+/-
366.1 
921.7+/-
164.4 
1223.6+/-
122.7 
1114.8+/-
164.1 
1251.5+/-
161.1 
1538.4+/-
133.4 
1231+/-
93.1 1211.9+/-78 
Hypothalamus                  
  PVN  
1738.4+/-
139.4 
1999.7+/-
213 
2484.4+/-
382 
2169.8+/-
257.6 
2352.7+/-
228.4 
2353.5+/-
228.4 
2210.6+/-
176.8 
2056.9+/-
134.7 
Lateral Septum 
935+/-
209.8 
828.5+/-
194.3 
723.6+/-
253.6 
343.7+/-
99.5 401+/-121.6 
1285.2+/-
263.1 
764.2+/-
223.8 
766.2+/-
154.6 
Lateral Habenula 
1488.3+/-
107.8 
1216.2+/-
200.9 
1181.4+/-
198.8 
608.2+/-
156.6* 
1037.8+/-
216.4 
1609.6+/-
125 
1066.2+/-
137.3 
1143.7+/-
180.6 
 
TABLE 2:  Phosphorylated ERK1/2 in various brain regions following ethanol 
sensitization in adolescent and adult mice.  Adolescent and adult DBA/2J mice were 
treated according to the Experimental Design Table 1.  The number of phosphorylated 
ERK1/2 pixels/mm2 is shown for each brain region examined.  Significant changes within 
a region are shown in bold.  * denotes groups that are significantly different compared to 
the saline control, p<0.05.  # denotes groups that are significantly different compared to 
acute ethanol 2.5 g/kg, p<0.05. 
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Effect of MPEP on Cocaine Sensitization.  In the adolescent group, MPEP had 
no effect on the acquisition of cocaine sensitization (Figure 13).  There was a significant 
main effect of cocaine treatment [F(4,80)=45.80, p<0.001], with greater distance traveled 
on each day as compared to the first day of cocaine exposure, ps<0.001.  This data 
pattern indicates the acquisition of cocaine sensitization.  The main effect of MPEP dose 
and the interaction were not significant.  The magnitude of sensitization was also not 
altered by MPEP pretreatment.  In the adult group, 30 mg/kg MPEP altered the 
acquisition pattern of cocaine sensitization (Figure 13C).  There was a significant main 
effect of MPEP treatment [F(2,84)=3.46, p=0.05], a significant main effect of cocaine 
exposure [F(4,84)=73.69, p<0.001], and a significant interaction [F(8,84)=3.66, p=0.001].   
Each MPEP treatment group showed acquisition of cocaine sensitization as 
evidenced by greater locomotor activity on each day relative to the first cocaine 
exposure (ps<0.001).  However, 30 mg/kg MPEP reduced activity relative to saline 
treatment on the first and second exposure to cocaine (ps<0.04).  The magnitude of 
cocaine sensitization was not altered by MPEP pretreatment.  Together these data 
suggest that while cocaine sensitization was observed in each group and the magnitude 
of sensitization was similar across groups, 30 mg/kg MPEP blunted the initial locomotor 
activation induced by cocaine.  
When tested for cocaine sensitization in the absence of any pretreatment, there 
were no significant differences in distance traveled among the adolescent groups or 
among the adult groups (Figure 13B & D).  This data indicates that blockade of mGluR5 
by 30 mg/kg MPEP during the initiation of cocaine sensitization did not alter the 
expression of cocaine sensitization. 
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Figure 13. Effect of MPEP on Cocaine Sensitization. 
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Figure 13. MPEP blunts the acute locomotor response to cocaine in adult mice only.  A. 
Distance traveled (cm, +/- SEM) in the first 15-minutes of the locomotor session on 
treatment days 1,3,5,7, and 9 in adolescent DBA/2J mice.  Mice were pretreated with 
MPEP (0, 10, or 30 mg/kg) 30-minutes prior to treatment with cocaine 10 mg/kg.  B. 
Distance traveled (cm, +/- SEM) in the first 15-minutes of the locomotor session on test 
day 10 following saline pretreatment 30-minutes prior to treatment with cocaine 10 
mg/kg in adolescent mice.  C.  A. Distance traveled (cm, +/- SEM) in the first 15-minutes 
of the locomotor session on treatment days 1,3,5,7, and 9 in adult DBA/2J mice.  Mice 
were pretreated with MPEP (0, 10, or 30 mg/kg) 30-minutes prior to treatment with 
cocaine 10 mg/kg.  *=significantly different compared to saline pretreated group, p<0.04.  
D.  Distance traveled (cm, +/- SEM) in the first 15-minutes of the locomotor session on 
test day 10 following saline pretreatment 30-minutes prior to treatment with cocaine 10 
mg/kg in adult mice.     
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DISCUSSION 
Adolescent DBA/2J mice are less sensitive than adult mice to ethanol sensitization 
(Stevenson et al. 2007).  However, the mechanisms mediating ethanol sensitization in 
adolescent or adult mice have not been fully characterized.  This study sought to 
determine the role of the metabotropic glutamate receptor subtype 5, along with the 
downstream kinase ERK1/2, in ethanol sensitization in adolescent and adult mice.  
Furthermore, the role of mGluR5 in cocaine sensitization in adolescent and adult mice 
was examined.  The results show that the mGluR5 antagonist MPEP blunts ethanol 
sensitization in adult mice only, and that both sensitization and the blunting of 
sensitization by MPEP occur in the absence of modulation of ERK1/2 phosphorylation.  
MPEP effected acute stimulant properties of cocaine in adult mice only, with no effect in 
adolescents.   
 Previous research has demonstrated that the mGluR5 antagonist MTEP blocks 
the expression of ethanol sensitization (Kotlinska et al. 2006).  Kotlinska et al. initiated 
sensitization by administering ethanol 2.4 g/kg 4 times, at 3-day intervals.  They then 
administered MTEP 15-minutes before an expression test for sensitization on day 14 
and showed that the mice receiving MTEP did not display sensitization.  The present 
study differed from the Kotlinska et al. study by administering MPEP, along with ethanol, 
on the days when sensitization was developing (days 2-10), but not on the test day, in 
order to determine the role of mGluR5 in the induction of sensitization.  Evidence has 
emerged that glutamatergic transmission is necessary for the induction of sensitization 
to cocaine, amphetamine, and opioids, indicating a common glutamatergic mechanism 
for locomotor sensitization to all drugs of abuse.  Together, these studies indicate that 
mGluR5 is important to both the induction and the expression of ethanol sensitization in 
adult mice. 
 61
 A growing body of literature indicates that mGluR5 is involved in the neural and 
behavioral effects of ethanol (see Introduction).  MGluR5 is also known to interact with 
the NMDA receptor, with research showing that mGluR5 agonists potentiate, while 
mGluR5 antagonists reduce, NMDA-mediated responses (Attucci et al. 2001; Awad et 
al. 2000).  NMDA receptors have been shown to be involved in many of ethanol’s 
effects, including ethanol sensitization (Broadbent and Weitemier 1999; Kotlinska et al. 
2006).  In fact, Kotlinska et al. showed that MTEP potentiates the effect of MK-801 on 
the blockade of the expression ethanol sensitization.  Further, MPEP increases the loss 
of righting reflex induced by both the NMDA receptor antagonist ketamine and ethanol 
(Sharko and Hodge 2008).  Taken together, these data indicate that MPEP may blunt 
the induction of ethanol sensitization by effecting ethanol’s interaction with both mGluR5 
and NMDA receptors.   
 A potential limitation to the present study is the possibility that MPEP is having 
effects on receptors other than mGluR5.  In vitro studies have shown that high 
concentrations (>20μM) of MPEP can inhibit NMDA receptors (O'Leary et al. 2000).  
Plasma MPEP levels in mice 30-minutes after treatment with 10 mg/kg MPEP were 0.7 
μM, which makes it highly unlikely that levels in the brain following 30 mg/kg MPEP 
would be sufficient to affect NMDA receptors directly (Anderson et al. 2003).  MPEP has 
also been reported to inhibit norepinephrine (NE) uptake by the norepinephrine 
transporter (Netzeband and Gruol 1995) and to have effects similar to the standard NET 
inhibitor desipramine in the locus coeruleus (Heidbreder et al. 2003).  However, this 
report could not rule out whether the in vivo effects of MPEP on NET inhibition were 
mediated by a direct interaction between MPEP and NET or through an mGluR5 
mediated pathway.  In fact, MPEP has been shown to mediate extracellular NE levels in 
the cortex via mGluR5 blockade (Page et al. 2005).  Page et al. compared the 
effectiveness of MPEP to the effectiveness of the newly discovered, more selective 
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mGluR5 antagonist, MTEP (Cosford et al. 2003).  MPEP and MTEP were found to have 
similar effectiveness in altering cortical NE levels (Page et al. 2005).  At this time, there 
is no data linking blunting of ethanol sensitization with NET inhibition.  Therefore, more 
experiments could be done to fully determine the link between MPEP and NET. 
 The present study shows that mGluR5 activity is involved in ethanol sensitization 
in adults, and that activity at mGluR5 is not involved in adolescent sensitization.  
Evidence that adolescent mice are less sensitive to ethanol sensitization than adult mice 
suggests that adolescent sensitization might involve a different mechanism than adult 
sensitization (Stevenson et al. 2007).  In fact, adolescent rodents are differentially 
sensitive to numerous effects of ethanol compared to adults, and this difference in 
sensitivity seems to be related to the ongoing development of neuronal systems in the 
adolescent brain (for review, see (Spear and Varlinskaya 2005)).  Previous studies 
examining the effect of ethanol on mGluR5 have all been conducted in adult animals, so 
it remains unknown what effects ethanol may be having at the mGluR5 in adolescents, if 
any. Studies have shown that adolescent rodents are more sensitive to the inhibition of 
NMDA receptors by ethanol in the hippocampus (Swartzwelder et al. 1995a; 1995b).  
Combined with the fact that NMDA receptor antagonists inhibit ethanol sensitization and 
that mGluR5 receptors increase the ethanol-induced inhibition of NMDA receptors, one 
might predict that MPEP would be more effective at preventing ethanol sensitization in 
adolescent rodents.  However, little is known about differences in age-dependent 
interactions between ethanol and glutamate receptors in other brain regions.  Further 
studies need to be conducted to determine the precise interactions between ethanol, 
NMDA receptors, and mGluR5 receptors before the present results can be explained.   
One goal of the present study was to examine the role of the MAP kinase ERK1/2 
in ethanol sensitization.  Blockade of ERK1/2 by SL327 has been shown to prevent the 
induction (or acquisition) of cocaine and amphetamine sensitization (Valjent et al. 2006).  
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Although the current study revealed changes in ERK1/2 related to ethanol treatment 
(central amygdala and dentate gyrus), no correlation was discovered between changes 
in pERK1/2 and the induction of ethanol sensitization to both doses of ethanol.  The 
increase in pERK1/2 in the nucleus accumbens shell in the ethanol (2.0 g/kg) sensitized 
adult group, but not the MPEP + ethanol treated adult group or the adolescent group, is 
intriguing.  The nucleus accumbens has been identified as a region critically important 
for the induction and expression of ethanol sensitization (Kalivas and Stewart 1991).  
Recently, it has been demonstrated that cocaine sensitization causes an increase in 
pERK1/2 in the nucleus accumbens (Mattson et al. 2005; Yoon et al. 2007).  The present 
data add to this growing literature of a role for ERK1/2 signaling in the nucleus 
accumbens playing an essential role in locomotor sensitization to certain doses of drugs 
of abuse.  The lack of an increase in pERK1/2 following ethanol (2.5 g/kg) sensitization 
could be explained by an interaction between the dose of ethanol administered and the 
time course of activation of pERK1/2.  It has been shown that ethanol dose-dependently 
alters pERK1/2 in mouse cortex (Kalluri and Ticku 2002).  In the present study, it is 
possible that an effect of ethanol (2.5 g/kg) sensitization on pERK1/2 might occur at a 
different time point than for ethanol (2.0 g/kg).  Without a full time course of the 
activation of ERK1/2 following ethanol sensitization, the immunohistochemistry data 
remain inconclusive for the role of pERK1/2 in ethanol sensitization.  
The present study found that adolescent and adult mice both displayed cocaine 
sensitization, and that cocaine sensitization was not altered by MPEP.  Recent studies 
comparing cocaine sensitization in adolescent and adult rats have shown conflicting 
results (Camarini et al. 2007; Frantz et al. 2007).  The Camarini study was performed in 
DBA/2J mice and found that adolescent mice displayed sensitization while adult mice did 
not.  The finding that adult mice did not show cocaine sensitization is unusual, as 
cocaine sensitization in adult mice has been shown repeatedly.  The Frantz study 
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showed that adolescent rats were less sensitive to cocaine sensitization, which we did 
not observe in the present study.  The difference between the two studies is the species 
employed (i.e. mice vs rats) and the age of the animals (P28-43 vs P37-52).  It is likely 
that development of key neurotransmitter systems such as dopamine and glutamate is 
different in the two rodent species and at the two different ages. 
The finding that acute cocaine-induced locomotor activity was inhibited by MPEP 
in the adult mice is in line with previous studies (Chiamulera et al. 2001; Herzig and 
Schmidt 2004; McGeehan et al. 2004).  The lack of an effect of mGluR5 antagonists on 
the induction and expression of cocaine sensitization is also in agreement with previous 
reports in adult rodents (Dravolina et al. 2006; Herzig and Schmidt 2004).  McGeehan et 
al. (2004) observed that MPEP did not inhibit the acute stimulant properties of high 
doses of the very selective and potent dopamine reuptake inhibitor, GBR12909.  High 
doses of GBR12909 cause larger and longer-lasting increases in dopamine release in 
the nucleus accumbens, and it is possible that the locomotor activity induced by these 
changes in dopamine release are not susceptible to mGluR5 regulation (McGeehan et 
al. 2004).  Cocaine sensitization also leads to similarly increased dopamine levels in the 
nucleus accumbens, which may explain why mGluR5 is able to block acute cocaine-
induced locomotor activity, but is ineffective at blocking the sensitized locomotor 
response.      
The differential effects of MPEP on ethanol and cocaine sensitization are likely 
due to the different mechanisms of action of the drugs and to the different sensitization 
methods employed for each drug.  As previously discussed, ethanol acts on numerous 
receptor systems, including directly on mGluR5, whereas cocaine blocks the reuptake of 
dopamine, serotonin, and norepinephrine (Minami et al. 1998; Ritz et al. 1987).   Chronic 
ethanol self-administration leads to an increase in mGluR5 mRNA in the nucleus 
accumbens, while chronic psychomotor stimulant injections lead to a decrease in 
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mGluR5 mRNA and an increase in mGluR1 mRNA in the nucleus accumbens (Mao and 
Wang 2001).  As it has been shown that cocaine sensitization is mediated by mGluR1 
but not mGluR5, it seems that these two mGlu receptors are playing different roles in 
sensitization depending on the drug (Dravolina et al. 2006).  It is not surprising that 
ethanol and cocaine sensitization involve different receptor systems, as it has been 
shown that the closely related drugs amphetamine and cocaine induce sensitization 
through different mechanisms (Vanderschuren and Kalivas 2000).   
Psychostimulant sensitization is known to be influenced by drug and 
environmental pairings (Crombag et al. 2000; Robinson et al. 1998).  It has been shown 
that much higher doses of cocaine or amphetamine are required to induce locomotor 
sensitization when the drug is given intravenously in the home cage rather than in a 
separate context, such as a locomotor chamber (Browman et al. 1998a; 1998b).  
However, ethanol sensitization can be expressed robustly when the drug is not paired 
with the locomotor chamber until the final test day (Fee et al. 2007).  Studies from our 
laboratory have revealed that ethanol sensitization often does not occur when ethanol is 
paired with the locomotor chambers repeatedly (unpublished observations).  In fact, it 
appears that ethanol sensitization is partially mediated by the novelty of the testing 
context (Meyer et al. 2005).  It was shown that If mice are tested again on the day 
following the test day (similar to day 11 in the present experiments), the mice show 
much less activity because the environment is not novel anymore, but they still show 
sensitization.  The authors proposed that this could be related to stress in a novel 
environment, as they have shown previously that restraint stress could cross sensitize 
with ethanol (Roberts et al. 1995).  Another group has shown that MPEP administration 
during social defeat stress blocks the expression of amphetamine sensitization in mice, 
but has no effect on amphetamine-induced amphetamine sensitization (Yap et al. 2005).  
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Therefore, it is possible that MPEP, a known anxiolytic, blocks ethanol sensitization by 
modifying the stress response to the “novel” environment of the locomotor chamber.   
The lack of an effect of MPEP on cocaine-induced acute locomotor activity and 
ethanol sensitization in adolescent mice is intriguing.  It has been shown that mGluR5 
mRNA expression remains about the same from P21 through adulthood, so it seems 
unlikely that the expression of mGluR5 underlies the age-dependent differences in 
sensitization and in the response to MPEP (Catania et al. 1994). To our knowledge, the 
present study is the first study of MPEP in adolescent rodents.  Therefore, it is not 
known if MPEP has similar effects on mGluR5 or similar metabolism in adolescent 
rodents as have been shown for adult rodents.  Studies of depression in adolescents 
have revealed that adolescents do not respond to tricyclic antidepressants in the same 
way as adults.  Tricyclic antidepressants inhibit reuptake of norepinephrine and 
serotonin.  A review of the literature has shown that although the NE transporter is fully 
expressed before the onset of adolescence, adult levels of innervation and NE synthesis 
are not reached until mid-adolescence, and this is likely the reason adolescents do not 
respond to tricyclic antidepressants (Bylund and Reed 2007).  In regard to glutamate, it 
has been shown that numerous excitatory synapses are being pruned during early 
adolescence (Spear 2000a).  This could mean that, although mGluR5 expression is not 
different in adolescents compared to adults, the location and activity of mGlu5 receptors 
differs from adults and causes them to respond differently to drugs such as MPEP.   
More studies on MPEP and adolescents are necessary to fully address this possibility.   
 The present study suggests that the mGluR5 antagonist MPEP blunts ethanol 
sensitization in adult mice while having no effect in adolescent mice.  The intracellular 
pathway by which MPEP is blunting ethanol sensitization does not appear to involve 
ERK1/2 signaling.  This study is the first to show that ethanol sensitization is mediated by 
different mechanisms in adolescent and adult DBA/2J mice.   
CHAPTER IV: EFFECT OF ETHANOL SENSITIZATION ON SUBSEQUENT 
ETHANOL SELF-ADMINISTRATION IN ADOLESCENT AND ADULT DBA/2J MICE 
INTRODUCTION 
Adolescence is a critical period of development during which children and young 
animals undergo adaptive changes in behavior and neurobiological systems that bring 
about the transition into adulthood.  Behavioral changes include spending an increased 
amount of time engaged in social interaction with peers, taking part in risky behaviors, 
and exploring novel situations, while neurobiological changes include remodeling in the 
cortex and mesolimbic regions such that glutamatergic and GABAergic 
neurotransmission is reduced and dopaminergic neurotransmission is increased (Spear 
2000a). 
 The behavioral and neurobiological adaptations that take place during this 
developmental stage cause the adolescent to be particularly vulnerable to experimenting 
with drugs of abuse and to subsequent drug-induced neuroadaptations (Crews et al. 
2007).  In these adolescents, alcohol exposure could disrupt the formation of neural 
networks and lead to increased drinking later in life (Spear 2002).  It is known that 
people who start drinking during adolescence are four times more likely to become 
alcohol dependent as adults (Grant 1998).  However, the mechanism(s) underlying this 
finding remain to be fully characterized.   
Studies in rodents have shown that adolescents and adults are differentially 
sensitive to the effects of acute and chronic ethanol exposure.  Adolescent rodents are 
more sensitive to the effects of ethanol on measures of acute locomotor stimulation, 
anxiety, ataxia, spatial memory, conditioned place preference, and social interaction as 
 
compared to adult rats (Hefner and Holmes 2007; Markwiese et al. 1998; Philpot et al. 
2003; Rajendran and Spear 2004; Varlinskaya and Spear 2002; Yttri et al. 2004).  By 
contrast, other studies have shown that adolescent rodents are less sensitive than adult 
rats to the sedative and motor impairing effects of ethanol, to ethanol withdrawal induced 
anxiety, and analgesia (Doremus et al. 2003; Hefner and Holmes 2007; Silveri and 
Spear 1998; Varlinskaya and Spear 2002; White et al. 2002).  These differences in the 
sensitivity of adolescents to ethanol are important because it has been shown that a 
decreased response to acute alcohol exposure during adolescence is a potent predictor 
of future alcoholism (Schuckit 1993; 1994).  
One model of neurobehavioral adaptations that occur following chronic ethanol 
exposure is locomotor sensitization.  Sensitization is typically defined as a progressive 
increase in locomotor activity following repeated administration of a drug of abuse 
(Kalivas and Stewart 1991).  The process of sensitization is thought to produce enduring 
adaptive changes in brain and behavioral function that may underlie components of 
addiction (Kalivas et al. 1998; Robinson and Berridge 2000).  Research has shown that 
sensitization is mediated by an interconnected network of mesocorticolimbic brain 
regions (i.e., VTA, nucleus accumbens, prefrontal cortex, amygdala, and thalamus) and 
neurotransmitter systems (i.e., dopamine, glutamate, and GABA) (Kalivas 1995; Vezina 
and Kim 1999).  These brain regions and neurotransmitter systems all undergo 
alterations during the adolescent developmental period (Kalivas 1995; Spear 2000a; 
Vezina and Kim 1999).  We have shown that adolescent mice are less sensitive to 
ethanol sensitization compared to adult mice (Stevenson et al. 2007).  Thus, 
sensitization models are useful tools to determine if adolescent vulnerability to addiction 
involves differential sensitivity to neurobehavioral changes that occur with repeated drug 
use.  
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Ethanol sensitization leads to an increase in subsequent ethanol self-
administration in adult DBA/2J mice (Camarini and Hodge 2004; Lessov et al. 2001).  It 
was shown that ethanol sensitized DBA/2J mice consumed more ethanol than both non-
sensitized mice and mice with one prior ethanol exposure.  Moreover, sons of alcoholics 
sensitize to the effects of repeated alcohol on motor activity, while the sons of non-
alcoholics show tolerance (Newlin and Thomson 1991).  Furthermore, adolescent and 
adult rats that are bred for high alcohol consumption display locomotor activation to 
ethanol, while low consuming rats do not (Rodd et al. 2004).  Sensitization to cocaine 
and amphetamine also leads to enhancement of self-administration of these drugs 
(Covington and Miczek 2001; Pierre and Vezina 1998; Vezina 2004; Vezina and Kim 
1999).  These studies indicate a relationship between locomotor sensitization and drug 
self-administration in adult rodents.  However, it is not known whether ethanol 
sensitization in adolescence will lead to subsequently greater ethanol self-administration 
in adulthood.   
Although previous data from our laboratory suggests that the ERK1/2 pathway is 
not involved in ethanol sensitization, it has been shown that chronic ethanol exposure 
followed by withdrawal leads to long-lasting changes in ERK1/2 phosphorylation (Sanna 
et al. 2002).  Evidence is emerging that the activity of ERK1/2 is modulated in reward-
associated brain regions in response to drugs of abuse, including ethanol (Berhow et al. 
1996; Kalluri and Ticku 2002; Tsuji et al. 2003; Valjent et al. 2000; Valjent et al. 2004).  
The ERK1/2 pathway is activated when phosphorylated by MEK1/2, which causes ERK1/2 
to phosphorylate gene transcription factors such as CREB and Elk-1.  The regulation of 
gene transcription by the ERK1/2 allows it to mediate long-term changes in behavioral 
functions (Grewal et al. 1999; Qi and Elion 2005; Sweatt 2004; Thomas and Huganir 
2004; Wang et al. 2007).  The ability of ERK1/2 to modulate long-term neurobiological 
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changes in response to drug administration makes it an intriguing molecular target for 
the long-term changes induced by locomotor sensitization.    
The present study sought to determine whether the neurobiological changes 
induced by repeated ethanol treatment during adolescence can lead to enhanced 
ethanol intake during adulthood.  Adolescent and adult DBA/2J mice were treated for 
ethanol sensitization and were subsequently tested for ethanol intake using a sucrose 
fading, two-bottle choice procedure.  In a separate experiment, mice were treated with 
the ERK1/2 inhibitor SL327 during sensitization and were then tested for ethanol intake to 
observe the long-lasting effects of ERK1/2 modulation on ethanol behaviors. 
 
MATERIALS AND METHODS 
Animals.  Male 3-week old (adolescent) and 8-week old (adult) DBA/2J mice 
(Jackson Laboratories, Bar Harbor, ME) were housed in groups (4 animals per cage) in 
standard Plexiglas cages with food (Purina Rodent Chow) and water available ad 
libitum.  The colony was maintained at 27oC on a 12-hour light/dark cycle, with the lights 
on at 10pm.  The behavioral experiments were conducted during the dark portion of the 
cycle.  Mice were handled and weighed daily for 1-week prior to, and for the duration of, 
the experiment.  Animals were under continuous care and monitoring by the Division of 
Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were carried out in 
accordance with the NIH Guide to Care and Use of Laboratory Animals (National 
Research Council, 1996) and institutional guidelines. 
 Behavioral Apparatus.  The locomotor activity (horizontal distance traveled, cm) 
of adolescent and adult mice was measured in eight covered Plexiglas chambers (30 
cm2, Med Associates, Georgia, VT).  Two sets of 16 pulse-modulated infrared 
photobeams were located on opposite walls to record ambulatory movements in the X-Y 
(horizontal) plane.  All software settings were the same for adults and adolescent mice.  
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The activity chambers were computer-interfaced (Med Associates) for data sampling at 
100-millisecond resolution.   
Experimental Procedures.  Mice were adapted to the colony and to handling for 
1-week (adolescents=P28; adults=P63).  On locomotor testing days, mice were taken in 
the home cage to the testing room at least 30-minutes prior to the session to habituate to 
the testing room.  The first two days of the each experiment were habituation days (H1 
and H2).  On these days, all mice received a pretreatment intraperitoneal (IP) injection of 
saline and were placed back into their home cages.  Thirty minutes after the 
pretreatment injection, mice were given an IP injection of saline and were immediately 
placed in the locomotor chamber for the 10 minute session. 
Experiment 1a: Ethanol Sensitization.  Adolescent and adult mice received an IP 
injection of 0, 2.0, or 2.5 g/kg ethanol (n=11-12 per age group per ethanol dose) and 
were immediately placed in the locomotor chamber for the 10 minute session.  Following 
the acute locomotor session on day 1 (D1), mice received the assigned ethanol dose (0, 
2.5, or 3.0 g/kg IP) once daily for nine days (D2-D10) in the home cage.  On day 11 
(D11), the mice were tested for locomotor sensitization.  Mice were injected with 0, 2.0, 
or 2.5 g/kg ethanol (IP) and placed in the locomotor chamber for 10 minutes 
Experiment 1b: Two-Bottle Choice.  Immediately following the locomotor session 
on day 11, all mice were separated into individual cages.  The mice were given 2.5 
weeks to acclimate to single housing.  On day 17 of single housing, the water bottles 
were removed from the cage top and replaced with two plastic 50-ml graduated drinking 
bottles.  Ethanol self-administration was induced using a sucrose fading procedure.  On 
the first four days, mice were given one bottle with a solution containing 10% 
sucrose/5% ethanol and one bottle containing water. On the next four days, mice were 
given access to one bottle containing 5% sucrose/5% ethanol solution and water.  
During the final four days, mice were given access to 5% ethanol (no sucrose) and 
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water.  The bottles were weighed daily to measure fluid intake, and the location of the 
solutions was alternated each day to control for side preferences.    
Experiment 2a: Effect of SL-327 on Ethanol Sensitization.  On day 1, adolescent 
and adult mice were given a pretreatment injection of 15% DMSO (dimethyl sulfoxide) 
and returned to their home cages.  Thirty minutes later, mice were injected with ethanol 
(0 or 2.0 g/kg) and immediately placed in the locomotor chamber for 10 minutes (n=8 per 
age group per pretreatment per ethanol dose).  On days 2-10, mice were given a 
pretreatment injection of SL327 (0 or 30 mg/kg) 30-minutes prior to an injection of 
ethanol (0 or 2.5 g/kg) in the home cage.  No locomotor testing was performed on these 
days.  On day 11, mice were given a pretreatment injection of 15% DMSO and returned 
to the home cage.  Thirty minutes later, mice were injected with ethanol (0 or 2.0 g/kg) 
and were immediately placed into the locomotor chamber to be tested for locomotor 
sensitization.  
Experiment 2b. Two-Bottle Choice.  Immediately following the locomotor session 
on day 11, all mice were separated into individual cages.  The mice were given 2.5 
weeks to acclimate to single housing.  On day 17 of single housing, the water bottles 
were removed from the cage top and replaced with two plastic 50-ml graduated drinking 
bottles.  Ethanol self-administration was induced using a sucrose fading procedure.  On 
the first four days, mice were given one bottle with a solution containing 10% 
sucrose/5% ethanol and one bottle containing 10% sucrose. On the next four days, mice 
were given access to one bottle containing 5% sucrose/5% ethanol solution and one 
bottle containing 5% sucrose.  During the final four days, mice were given access to 5% 
ethanol and water (no sucrose).  The bottles were weighed daily to measure fluid intake, 
and the location of the solutions was alternated each day to control for side preferences.     
Drugs.  For the sensitization experiments, ethanol (95% w/v) was diluted in 
saline (0.9%) to a concentration of 20% (v/v) and injected (IP) at different volumes to 
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achieve the appropriate dosage (i.e., 2.0 and 2.5 g/kg).  The MEK/ERK1/2 inhibitor SL327 
(Tocris, Ellisville, MO) was dissolved in 15% DMSO.  SL327 was injected IP at a volume 
of 10 mL/kg.  For the two-bottle choice experiments, ethanol (95% w/v) was diluted in 
distilled water to a concentration of 5% (v/v).  Sucrose (w/v; 5 or 10%) was dissolved in 
the ethanol solution or in distilled water alone.   
Behavioral Measures and Data Analysis.  Horizontal distance traveled (in 
centimeters) during the 10-minute session was calculated from the number of 
photobeam breaks and presented as mean ± SEM.  Statistical significance was defined 
as p≤0.05 in all experiments.      
Experiment 1a: Ethanol Sensitization.  Distance traveled (cm) was analyzed 
separately for adolescents and adults using one-way repeated measure (RM) ANOVA, 
with day (D1 and D11) as the factor.  Sensitization was defined as activity on day 11 
being significantly greater than activity on day 1 within an ethanol each ethanol dose, as 
determined by post-hoc Tukey tests. The data were presented as mean (+/- SEM). 
Experiment 1b.  Two-Bottle Choice.  Ethanol intake (g/kg) was determined from 
daily measurements of bottle weight and averaged across the four days of access to 
each solution.  Ethanol preference (%) was determined by dividing ethanol solution 
intake by total fluid intake.  The intake and preference of the age groups were analyzed 
separately using two-way repeated measure (RM) ANOVA, with sensitization treatment 
(ethanol 0, 2.0, or 2.5 g/kg) and ethanol drinking solution as factors.  Post-hoc Tukey’s 
test was used to extract group differences.  The data were presented as mean (+/-SEM). 
In order to determine if degree of sensitization was related to ethanol intake 
(g/kg), a linear regression analysis was conducted comparing the degree of sensitization 
(sensitization index: (day 11 activity/day 1)*100) for the two doses of ethanol (2.0 and 
2.5 g/kg) within each age group to the average ethanol intake (g/kg) of each solution.    
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Experiment 2a: Effect of SL327 on Ethanol Sensitization.   Distance traveled (cm) 
was analyzed separately for adolescents and adults using two-way repeated measure 
(RM) ANOVA, with pretreatment (SL327 0 or 30 mg/kg) and day (D1 and D11) as 
factors.  Sensitization was defined as activity on day 11 being significantly greater than 
activity on day 1 within a treatment group, as determined by post-hoc Tukey tests. The 
data were presented as mean (+/- SEM). 
Experiment 2b: Two-Bottle Choice.  Ethanol intake (g/kg) was determined from 
daily measurements of bottle weight and averaged across the four days of access to 
each solution. Ethanol preference (%) was determined by dividing ethanol solution 
intake by total fluid intake.  The intake and preference of the age groups were analyzed 
separately using three-way repeated measure (RM) ANOVA, with the between subject 
factors pretreatment (vehicle or SL327) and sensitization treatment (ethanol 0 or 2.0 
g/kg), and the within subject factor ethanol drinking solution.  Post-hoc Tukey’s test was 
used to extract group differences.  Significant differences were examined using lower 
order ANOVA, where appropriate.  Planned comparisons were used to compare intake 
of the vehicle/ethanol group versus the SL327/ethanol group.  The data were presented 
as mean (+/-SEM).  Statistical significance was set at p<0.05. 
In order to determine if degree of sensitization was related to ethanol intake 
(g/kg), a linear regression analysis was conducted comparing the degree of sensitization 
(sensitization index: (day 11 activity/day 1)*100) for the vehicle and SL327 pretreated 
ethanol sensitization groups, within each age group, to the average ethanol intake (g/kg) 
of each solution.    
 
RESULTS 
Ethanol Sensitization.  As we have previously reported, adolescent mice did not 
display ethanol sensitization to ethanol (2.0 g/kg) but they did sensitize to ethanol (2.5 
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g/kg).  Adults showed sensitization to ethanol (2.0 and 2.5 g/kg; Figure 14; Stevenson et 
al., 2007).  In the adolescents, treatment with ethanol (2.5 g/kg) caused a significant 
increase in locomotor activity on day 11 compared to day 1 [F(1, 9)=6.42; p=0.03].  For 
the adults, treatment with ethanol (2.0 and 2.5 g/kg) induced a significant increase in 
locomotor activity on day 11 compared to day 1 [F(1, 10)=37.85; p<0.001][F(1, 
11)=96.58; p<0.001].   
 
 
 
Figure 14. Ethanol Sensitization. 
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Figure 14. Ethanol sensitization in adolescent and adult DBA/2J mice. A. Distance 
traveled (cm, +/- SEM) following treatment with saline on habituation day 2 and ethanol 
(0, 2.0, and 2.5 g/kg) on days 1 and 11 in adolescent mice. Ethanol 2.5 g/kg elicited 
significant sensitization. B. A. Distance traveled (cm, +/- SEM) following treatment with 
saline on habituation day 2 and ethanol (0, 2.0, and 2.5 g/kg) on days 1 and 11 in adult 
mice.  Ethanol 2.0 and 2.5 g/kg elicited significant sensitization. 
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Two-Bottle Choice.  The mice were not treated for the 17 days following ethanol 
sensitization in order to allow the adolescent mice to become adults.  At this time, the 
sucrose fading procedure began (Figure 15).  Analysis of ethanol intake in the 
adolescent mice showed only a main effect of sucrose concentration in the drinking 
solution [F(2, 60)=114.32; p<0.001].  This effect showed that the adolescents drank 
significantly more sucrose 10%/ethanol 5 % than sucrose 5%/ethanol 5% and ethanol 
5%, and more sucrose 5%/ethanol 5% than ethanol 5% (p<0.001).  The data for ethanol 
preference showed the same pattern; that is, only a significant main effect of drinking 
solution [F(2, 59)=132.07; p<0.001].  The lack of an effect of sensitization treatment 
indicates that ethanol sensitization did not influence subsequent ethanol intake or 
preference in the adolescent mice. 
In the adult mice, two-way RM ANOVA showed the same pattern as in the 
adolescents.  A significant main effect of drinking solution was found [F(2, 62)=76.92; 
p<0.001], indicating that the adult mice drank more solution when the sucrose 
concentration was higher.  Ethanol preference showed the same pattern of results in the 
adults, with only a significant main effect of drinking solution [F(2, 62)=69.21; p<0.001].  
Therefore, there was no effect of ethanol sensitization on ethanol intake or preference in 
adolescent or adult mice. 
In order to determine whether the degree of sensitization in each mouse 
correlated with ethanol intake, a linear regression was performed (Figure 16).  The 
sensitization index was calculated by determining the percentage increase in locomotor 
activity on day 11 compared to day 1, with 100% being an equal amount of activity on 
each day.  The linear regression showed that the degree of sensitization at either 
ethanol dose (2.0 or 2.5 g/kg) was not correlated with ethanol intake in the adolescent or 
adult mice.       
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Figure 15. Ethanol Intake and Preference. 
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Figure 15.  Ethanol sensitization does not affect subsequent ethanol intake or 
preference in adolescent or adult DBA/2J mice. A. Ethanol intake (g/kg) in the sucrose 
fading procedure in adolescent mice previously treated for sensitization with ethanol (0, 
2.0, or 2.5 g/kg).  B. Ethanol intake (g/kg) in the sucrose fading procedure in adult mice 
previously treated for sensitization with ethanol (0, 2.0, or 2.5 g/kg).  C. Ethanol 
preference (%) in the sucrose fading procedure in adolescent mice previously treated for 
sensitization with ethanol (0, 2.0, or 2.5 g/kg).  D. Ethanol preference (%) in the sucrose 
fading procedure in adult mice previously treated for sensitization with ethanol (0, 2.0, or 
2.5 g/kg). 
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Figure 16. No Correlation Between Ethanol Intake and Sensitization. 
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Figure 16.  No correlation between ethanol intake and level of ethanol sensitization in 
adolescent or adult DBA/2J mice.  A. Linear regression of ethanol intake (g/kg) as a 
function of level of ethanol 2.0 g/kg sensitization (distance traveled on day 11/distance 
traveled on day 1 X 100, %) in adolescent mice.  B. Linear regression of ethanol intake 
(g/kg) as a function of level of ethanol 2.0 g/kg sensitization (distance traveled on day 
11/distance traveled on day 1 X 100, %) in adult mice.  C. Linear regression of ethanol 
intake (g/kg) as a function of level of ethanol 2.5 g/kg sensitization (distance traveled on 
day 11/distance traveled on day 1 X 100, %) in adolescent mice.  D. Linear regression of 
ethanol intake (g/kg) as a function of level of ethanol 2.5 g/kg sensitization (distance 
traveled on day 11/distance traveled on day 1 X 100, %) in adult mice. 
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Effect of SL327 on Ethanol Sensitization.  Results in Figure 17 indicate that 
SL327 30 mg/kg did not alter ethanol sensitization in adolescent or adult DBA/2J mice.  
Two-way RM ANOVA of the adolescents revealed no significant effects, indicating that 
no sensitization developed in the adolescents.  In the adults, two-way RM ANOVA 
showed a significant main effect of day [F(1, 13)=77.49; p<0.001], indicating that the 
adults developed sensitization.  Overall, SL327 had no effect on ethanol sensitization in 
adolescent or adult mice at the dose and pretreatment time used in this study. 
 
Figure 17. SL327 Does Not Alter Ethanol Sensitization. 
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Figure 17.  SL327 (30 mg/kg) does not alter ethanol sensitization in adolescent or adult 
DBA/2J mice.  A.  Distance Traveled (cm, +/- SEM) following saline treatment on 
habituation day 2 and ethanol treatment (2.0 g/kg) on days 1 and 11 in adolescent mice.  
Mice were treated with SL327 (0 or 30 mg/kg) 30-minutes prior to ethanol (2.5 g/kg) on 
days 2-10.  B. Distance Traveled (cm, +/- SEM) following saline treatment on habituation 
day 2 and ethanol treatment (2.0 g/kg) on days 1 and 11 in adult mice.  Mice were 
treated with SL327 (0 or 30 mg/kg) 30-minutes prior to ethanol (2.5 g/kg) on days 2-10. 
 
 
 
 
 
 
 
 80
Two-Bottle Choice.  As in the previous two-bottle choice experiment, the mice 
were not treated for the 17 days following ethanol sensitization in order to allow the 
adolescent mice to reach adulthood.  The sucrose fading procedure was altered in order 
to more closely match that of Camarini and Hodge, 2004.  For the adolescent group, 
three-way RM ANOVA of ethanol intake revealed only a significant main effect of the 
within-subject factor ethanol solution [F(1, 27)=118.96; p<0.001], indicating that the mice 
drank less ethanol solution as the sucrose was faded out (Figure 18).  Similarly, analysis 
of the preference data showed only a main effect of ethanol solution [F(1, 27)=69.54; 
p<0.001].  There were no effects of SL327 pretreatment of ethanol treatment on ethanol 
intake of preference in the adolescent mice.  
Due to the main effect of ethanol solution on ethanol intake and preference, the 
data were analyzed separately for each solution.  In the analysis of sucrose 10%/ethanol 
5% preference, a main effect of pretreatment was revealed [F(1, 27)=4.90; p<0.04].  This 
indicated that adolescent mice receiving pretreatment with SL327 during sensitization 
preferred s10/e5% more than vehicle pretreated mice.  Planned comparison t test of 
s10/e5% preference revealed that SL327/ethanol treated mice preferred the solution 
significantly more than vehicle/saline treated mice (p=0.006).  No other significant 
differences were discovered.      
In the adult mice, three-way RM ANOVA of ethanol intake revealed significant 
main effects of the within subject factor ethanol solution [F(1, 27)=61.32; p<0.001] and 
the between subject factors pretreatment [F(1, 27)=8.53; p=0.007] and ethanol treatment 
[F(1, 27)=9.59; p=0.005].  Analysis of ethanol preference in the adults revealed 
significant main effects of the within subject factor ethanol solution [F(1, 27)=43.13; 
p<0.001] and the between subject factors pretreatment [F(1, 27)=6.58; p=0.016] and 
ethanol treatment [F(1, 27)=17.73; p<0.001].  Together, these data indicate that 
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treatment with SL327 or with ethanol (2.0 g/kg) during ethanol sensitization caused an 
increase in ethanol intake and preference in the adult mice.   
Due to the main effect of drinking solution on intake and preference, the data 
were analyzed separately for each solution.  Analysis of s10/e5% intake showed a 
significant main effect of pretreatment [F(1, 27)=4.82; p<0.04] and a significant main 
effect of ethanol treatment [F(1, 27)=5.09; p<0.04].  Adult mice pretreated with SL327 or 
treated with ethanol drank significantly more ethanol solution than vehicle or saline 
treated mice (p<0.04).  Preference of s10/e5% was significantly increased by treatment 
with ethanol [F(1, 27)=12.79; p=0.001].  Intake of s5/e5% showed similar effects, with a 
significant main effect of pretreatment [F(1, 27)=7.63; p=0.01] and treatment [F(1, 
27)=10.96; p=0.003].  Preference for s5/e5% also revealed a significant main effect of 
pretreatment [F(1, 27)=6.67; p<0.02] and treatment [F(1, 27)=16.24; p<0.001].  Finally, 
analysis of ethanol (5%) preference revealed a significant main effect of ethanol 
treatment [F(1, 27)=5.17; p<0.05].  Together, these data indicate that pretreatment with 
SL327 or treatment with ethanol leads to an increase in ethanol solution intake and 
preference in adult mice.  Planned t-test was used to examine differences in intake and 
preference between the vehicle/ethanol group and the SL327/ethanol group.  Intake of 
s10/e5% and intake and preference of s5/e5% was significantly greater in the 
SL327/ethanol group compared to the vehicle/ethanol group (ps<0.04).  These planned 
comparisons show that the combination of SL327 and ethanol during ethanol 
sensitization has an additive effect on increasing future ethanol intake and preference. 
In order to examine whether the level of ethanol sensitization correlated with 
ethanol intake, a linear regression was performed (Figure 19).  The results indicate that 
the level of sensitization did not correlate with ethanol intake in the adolescent or adult 
mice.   
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Figure 18. Ethanol Intake and Preference. 
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Figure 18.  Ethanol sensitization and SL327 treatment increase subsequent ethanol 
intake and preference in adult DBA/2J mice only.  A.  Ethanol intake (g/kg) in the 
sucrose fading procedure in adolescent mice previously treated with SL327 (0 or 30 
mg/kg) and ethanol (0 or 2.0 g/kg).  B. Ethanol intake (g/kg) in the sucrose fading 
procedure in adult mice previously treated with SL327 (0 or 30 mg/kg) and ethanol (0 or 
2.0 g/kg).  C. Ethanol preference (%) in the sucrose fading procedure in adolescent mice 
previously treated with SL327 (0 or 30 mg/kg) and ethanol (0 or 2.0 g/kg).  D. Ethanol 
preference (%) in the sucrose fading procedure in adult mice previously treated with 
SL327 (0 or 30 mg/kg) and ethanol (0 or 2.0 g/kg). *=significant main effect of SL327 
pretreatment, p<0.05.  +=significant main effect of ethanol treatment, p<0.05. 
#=significant effect of SL327/ethanol compared to vehicle/ethanol by t-test; p<0.05. 
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Figure 19. No Correlation Between Ethanol Intake and Sensitization. 
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Figure 19.  No correlation between ethanol intake and level of ethanol sensitization in 
adolescent or adult DBA/2J mice.  A. Linear regression of ethanol intake (g/kg) as a 
function of level of ethanol 2.0 g/kg sensitization (distance traveled on day 11/distance 
traveled on day 1 X 100, %) in adolescent mice pretreated with vehicle (SL327 0 mg/kg).  
B. Linear regression of ethanol intake (g/kg) as a function of level of ethanol 2.0 g/kg 
sensitization (distance traveled on day 11/distance traveled on day 1 X 100, %) in 
adolescent mice pretreated with SL327 (30 mg/kg).  C. Linear regression of ethanol 
intake (g/kg) as a function of level of ethanol 2.0 g/kg sensitization (distance traveled on 
day 11/distance traveled on day 1 X 100, %) in adult mice pretreated with vehicle 
(SL327 0 mg/kg).  D. Linear regression of ethanol intake (g/kg) as a function of level of 
ethanol 2.0 g/kg sensitization (distance traveled on day 11/distance traveled on day 1 X 
100, %) in adult mice pretreated with SL327 (30 mg/kg). 
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DISCUSSION 
Previous studies have shown that ethanol sensitized adult DBA/2J mice self-
administer more ethanol than non-sensitized mice (Camarini and Hodge 2004).  Since it 
has been proposed that adolescents are particularly vulnerable to ethanol-induced 
neuroadaptations that may lead to future alcoholism, this study examined ethanol intake 
during adulthood in mice that had been treated for ethanol sensitization as adolescents.  
The results of this study are surprising, as it was discovered that mice exposed to 
ethanol during adolescence did not show increased ethanol intake in adulthood, 
whereas mice that were treated during adulthood did show subsequent increases in 
ethanol intake.  The results also suggest that inhibition of ERK1/2 during ethanol 
sensitization can result in subsequently greater ethanol intake and preference in the 
adult mice.  
 In the first experiment, neither the adolescent nor adult mice showed an increase 
in ethanol intake or preference following ethanol (2.0 or 2.5 g/kg) sensitization treatment.  
This finding is likely due to a difference in the sucrose fading procedure employed in the 
present study as compared to previous work (Camarini and Hodge 2004).  In the present 
study, mice were first given one bottle containing sucrose (10%) and one containing 
water.  All the mice showed greater than 98% preference for the sucrose solution over 
the water solution (data not shown).  This indicates that the DBA/2J mice in the present 
study have a high preference for a sweetened solution compared to water.  As the 
sucrose was faded out of the solution, all the groups showed high intake levels of the 
sweetened solution compared to water.  A comparison of ethanol preference in the 
saline groups from Figure 15 and Figure 18 showed that the mice preferred sweetened 
ethanol much more versus water (Figure 15) than versus sucrose alone (Figure 18).  
Together, this data pattern suggests that sucrose fading versus water is not an accurate 
measurement of ethanol intake because the DBA/2J mice will drink high levels of 
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sweetened ethanol for the sucrose component (Figure 15).  In the second experiment, 
when both solutions were sweetened (Figure 18; Camarini and Hodge 2004), the effects 
of previous ethanol treatment on ethanol intake can be revealed because intake and 
preference for ethanol can be dissociated from intake and preference of sucrose. 
Evidence of a link between locomotor sensitization and drug self-administration is 
mixed.  For ethanol, previous research has indicated an increase in self-administration 
following repeated ethanol treatment in DBA/2J and C57BL/6, but the repeated ethanol 
treatment did not elicit locomotor sensitization (Camarini and Hodge 2004).  Another 
study found that voluntary ethanol consumption in C57BL/6 mice could elicit subsequent 
ethanol sensitization (Lessov et al. 2001).  The present study found an increase in 
ethanol self-administration in DBA/2J adult mice following ethanol sensitization, while the 
adolescent mice, which did not show sensitization, did not show an increase in self-
administration.  One conclusion to be drawn from the present data is that locomotor 
sensitization to ethanol is necessary for subsequent ethanol self-administration.  
However, the correlation data indicate no relationship between locomotor activity and 
ethanol intake in any group. This would indicate that repeated ethanol treatment in 
adults could lead to an increase in ethanol intake that is not related to locomotor activity.  
In fact, many studies show that drug exposure leads to subsequent increases in drug 
self-administration or reward, unrelated to sensitized locomotor activity (Horger et al. 
1992; Lorrain et al. 2000; Valadez and Schenk 1994).  Further, pretreatment with 
amphetamine, morphine, and cocaine leads to enhanced conditioned place preference 
of these drugs (Lett 1989).  Overall, there appears to be a link between drug pre-
exposure and drug self-administration in adult animals but locomotor response to 
ethanol appears to be dissociated from this effect. 
  Dopamine neurotransmission between the ventral tegmental area and the 
nucleus accumbens is thought to underlie both the acute effects of drugs, including 
 87
locomotor activity, and drug self-administration (Wise and Bozarth 1987).  For the 
psychomotor stimulant drugs, locomotor sensitization leads to a sensitized dopamine 
release in the nucleus accumbens, which is though to underlie locomotor sensitization 
and subsequent self-administration (Vezina 2004).  However, ethanol may differ from 
other drugs of abuse as it has been shown that ethanol sensitization does not cause a 
sensitized dopamine response in the nucleus accumbens (Zapata et al. 2006).  These 
data indicate that the link between ethanol sensitization and ethanol self-administration 
may involve other neurotransmitters.   
Glutamate has been shown to be a major player in psychostimulant sensitization, 
and previous evidence from our lab and others has shown that antagonists of glutamate 
receptors can inhibit both ethanol sensitization and ethanol self-administration 
(Broadbent et al. 2003; Hodge et al. 2006; McMillen et al. 2004; Vanderschuren and 
Kalivas 2000). Therefore, it is possible that long-lasting upregulation of glutamatergic 
neurotransmission underlies the ability of ethanol sensitization to increase ethanol self-
administration in the present study.  It has been shown that glutamate 
neurotransmission, and not dopamine neurotransmission, in the nucleus accumbens 
mediates relapse to cocaine seeking (Cornish and Kalivas 2000).  Furthermore, it has 
been shown that glutamatergic neurotransmission is being pruned throughout 
adolescence.  Perhaps these ongoing changes in glutamate transmission prohibit an 
increase in ethanol self-administration in the adolescent mice.  
The data from the present study implicate long-lasting changes in ERK1/2 
signaling as a mediator of increased ethanol intake.  It has been shown that both chronic 
ethanol exposure and SL327 treatment inhibit ERK1/2 phosphorylation, and that chronic 
ethanol exposure followed by withdrawal leads to long-lasting changes in ERK1/2 
phosphorylation (Sanna et al. 2002).  The present study suggests that inhibition of 
ERK1/2 phosphorylation with SL327, while simultaneously effecting ERK1/2 
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phosphorylation with ethanol (2.0 g/kg), leads to an increase in ethanol intake 17 days 
later in adult mice.  It is known that the ERK1/2 signaling cascade is downstream from G-
protein coupled receptors and Ca2+ signaling, which can be mediated by glutamate and 
dopamine receptors (Haddad 2005; Roberson et al. 1999).  We hypothesize that ethanol 
and SL327 during ethanol sensitization lead to a decrease in ERK1/2 phosphorylation, 
and this is followed by a subsequent increase in ERK1/2 phosphorylation during 17 days 
with no treatment.  Increases in ERK1/2 phosphorylation might cause changes in gene 
expression and synaptic plasticity that could lead to the increase in ethanol intake 
observed in the present study (Di Cristo et al. 2001; Grewal et al. 1999; Qi and Elion 
2005; Sweatt 2004; Thomas and Huganir 2004; Wang et al. 2007).  In fact, it has 
recently been shown that cocaine sensitization in adult rats followed by 14-days of 
withdrawal leads to an increase in phosphorylated ERK1/2.  This increase in pERK1/2 was 
associated with an increase in AMPA receptor expression in the nucleus accumbens of 
previously sensitized rats (Boudreau et al. 2007).  As it has been shown repeatedly that 
AMPA receptors are involved in drug-seeking in adult rodents, the authors hypothesized 
that the increase in AMPA receptors might cause the sensitized animals to be at a 
greater vulnerability for drug-seeking (Boudreau and Wolf 2005; Fasano and Brambilla 
2002; Gerdeman et al. 2003; Sutton et al. 2003; Winder et al. 2002).  Therefore, a 
similar cascade of events might underlie the propensity of the sensitized and/or SL327 
treated adult mice in the current study to drink more ethanol.  Interestingly, a study 
comparing the long-lasting effects of nicotine exposure during adolescence or adulthood 
on AMPA receptor expression showed that, two-months after nicotine treatment, AMPA 
receptor expression in the striatum was decreased in the animals exposed during 
adolescence and increased in the animals exposed during adulthood (Adriani et al. 
2004).  Thus, it is possible that the adolescent mice in the present study did not increase 
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ethanol intake because of developmental differences in ethanol-induced AMPA receptor 
expression in the nucleus accumbens.    
The present study showed that ethanol sensitization treatment during adulthood, 
but not adolescence, leads to a subsequent increase in ethanol intake and preference.  
The data revealed that this effect is enhanced by inhibition of ERK1/2 phosphorylation, 
possibly downstream from glutamate receptors, and that the differences in adolescent 
and adult mice might be due to differences in glutamate signaling during development.  
As it has been proposed that adolescents are more vulnerable to drug-induced 
neuroadaptations which lead to a propensity to develop alcoholism in adulthood (Spear 
2000a), we hypothesized that ethanol sensitization in adolescent mice would cause a 
significant increase in ethanol intake during adulthood.  The results of this study, 
however, suggest that ethanol sensitization is not a model of the adolescent vulnerability 
to alcoholism.  Instead, ethanol sensitization appears to be a model of adult 
neurobiological changes that occur which can lead to the propensity to increase ethanol 
intake.    
 
 
 
 
 
 
 
 
 
 
CHAPTER V: GENERAL CONCLUSIONS 
DISCUSSION 
The results from the three sets of experiments show that adolescent DBA/2J 
mice are less sensitive to ethanol sensitization, to the modulation of ethanol sensitization 
by the mGluR5 antagonist MPEP, and to ethanol intake following ethanol sensitization.  
These data add to a growing body of literature indicating that adolescent rodents are 
differentially sensitive to drugs of abuse.  The age-dependent differences in sensitivity 
have been proposed to be due to the ongoing developmental neurobiological changes in 
the adolescent brain, and the present studies support this theory.   
Pierce and Kalivas (1997) proposed that the neurobiological changes which 
underlie locomotor sensitization include increased glutamatergic output from the 
prefrontal cortex to the nucleus accumbens and VTA along with increased dopaminergic 
output from the VTA to the nucleus accumbens, as shown in Figure 20.  We propose 
that adolescent mice are less sensitive to ethanol sensitization based on the 
neurobiological changes taking place during the developmental period, as illustrated in 
Figure 21.  These changes include decreased glutamatergic output from the prefrontal 
cortex to the nucleus accumbens and VTA, which are opposite to the critical increases in 
glutamatergic output which underlie adult sensitization.   
The possibility that differences in glutamatergic system development are 
important for age-dependent differences in sensitization is supported by the second set 
of experiments.  That is, the metabotropic glutamate receptor subtype 5 antagonist 
MPEP was able to significantly blunt ethanol sensitization in the adult mice, but was 
ineffective in altering sensitization in the adolescent mice (Figure 22).  Along with 
 
studies from other laboratories, it seems clear that glutamate neurotransmission is 
critical for ethanol sensitization in adult mice.  In adolescent mice, however, MPEP did 
not blunt ethanol (2.5 g/kg) sensitization which indicates that mGluR5 may not be 
involved in adolescent ethanol sensitization.  It is possible that in adolescent mice, 
dopaminergic or GABAergic neurotransmission is more important for ethanol 
sensitization than glutamatergic neurotransmission.  It has been shown that ethanol 
induces greater GABA receptor-mediated inhibitory postsynaptic currents in adult rats 
compared to adolescent rats (Li et al. 2006).  We can speculate that the high ethanol 
dose (2.5 g/kg) in adolescent mice is able to elicit strong enough GABA-mediated 
inhibition from the nucleus accumbens to the ventral pallidum, thus allowing ethanol 
sensitization to develop independent of glutamatergic input to the nucleus accumbens.  
Since glutamatergic signaling is critical for adult ethanol sensitization, it is unclear why 
GABA might be more important in adolescent sensitization. 
It has been proposed that age-dependent differences in sensitivity to ethanol 
might underlie the propensity for ethanol intake during adolescence to lead to alcoholism 
later in life (Spear and Varlinskaya 2005).  The finding that adolescents are less 
sensitive to ethanol sensitization is significant because it has been shown in humans 
that sons of alcoholics, a group at high risk for developing alcoholism, are differentially 
sensitive to the physiological effects of ethanol when given repeated ethanol treatments 
(Newlin and Thomson 1991).  It is possible, therefore, that blunted sensitivity to the 
neuroadaptations that occur during the induction of ethanol sensitization in adolescents 
may be one factor that contributes to the epidemiological observation that adolescent 
alcohol use is associated with increased risk of abuse in adulthood (Grant and Dawson 
1998) 
The final set of experiments was designed to directly assess the hypothesis that 
adolescent mice are more vulnerable than adult mice to the long-term neurobiological 
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changes induced by ethanol sensitization.  In this experiment, all mice were treated for 
ethanol sensitization, followed by two-bottle sweetened ethanol intake 17 days later.  
The results indicate that adolescent mice are less vulnerable than adult mice to the 
effects of ethanol sensitization on subsequent ethanol intake.  That is, ethanol 
sensitization in the adult mice caused a subsequent increase in ethanol intake and 
preference, whereas ethanol sensitization in adolescent mice caused no changes in 
subsequent ethanol intake or preference.  Although the results could be due to several 
factors, as presented in the experiment 3 discussion section, it is possible that ethanol 
sensitization is not an appropriate measure of the adolescent vulnerability to alcoholism.  
In both the adolescent and adult mice, ethanol sensitization was not correlated with 
ethanol intake.  This would indicate that locomotor activity is dissociated from drug 
intake, and therefore may not be the best available method for assessing the 
neuroadaptations that lead to drug intake.   
This conclusion is further supported by the results from the second part of 
experiment 3.  In this study, adult mice that received the drug SL327 during ethanol 
sensitization did not show any difference in sensitization compared to vehicle treated 
mice.  However, treatment with SL327 during ethanol sensitization caused a significant 
increase in subsequent ethanol intake in the adult mice.  These results indicate that a 
drug which does not alter ethanol sensitization is able to affect ethanol intake, again 
dissociating ethanol sensitization from intake. 
Despite the lack of a correlation between locomotor sensitization and ethanol 
intake, the results suggest that changes in glutamatergic signaling induced by repeated 
ethanol treatment in the adult mice can affect subsequent ethanol intake.  The models in 
Figures 23 and 24 show the proposed changes that may occur following ethanol 
sensitization treatment in the adult mice, which could underlie the later increase in 
ethanol intake and preference.  That is, chronic ethanol exposure leads to a 
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downregulation of ERK1/2 phosphorylation.  When ethanol is no longer present, this 
downregulation is followed by a compensatory upregulation in ERK1/2 phosphorylation.  
When ethanol is re-introduced, there is even greater upregulation of ERK1/2 
phosphorylation, and this upregulation may underlie a progressive increase in ethanol 
intake (Sanna et al. 2002).  We hypothesize that the upregulation in ERK1/2 
phosphorylation leads to an increase in glutamate signaling from the prefrontal cortex to 
the nucleus accumbens, and that this increase in glutamatergic neurotransmission is 
responsible for the greater levels of ethanol intake observed in the present study (Figure 
24). 
Overall, the clinical data clearly show that human adolescents are vulnerable to 
drug-induced neuroadaptations that lead to an enhanced susceptibility to alcoholism.  
The present studies add to the rodent literature showing that adolescents respond 
differently than adults to drugs of abuse, including ethanol.  This differential responding 
is likely due to the ongoing neurobiological changes that take place during the 
adolescent period, such as the pruning of glutamatergic synapses.  These experiments 
raise the concern that ethanol sensitization may not be the best method for modeling the 
adolescent vulnerability to future alcoholism.  
 
FUTURE DIRECTIONS 
Future studies will examine the brain regional involvement in ethanol 
sensitization in both adolescent and adult mice.  In the present experiments, c-Fos and 
ΔFosB immunohistochemistry did not show any sensitization-related changes in 
expression (data not shown).  Future experiments will use immunohistochemistry to the 
transcription factor CREB, which has been linked to numerous addiction related 
behaviors (Pandey 2004).  This examination will elucidate gene-expression changes in 
brain regions that might underlie the behavioral differences observed in the two age-
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groups.  In order to further probe the lack of an effect of MPEP in adolescents, 
immunohistochemical analysis examining mGluR5 expression in adolescent and adult 
mice should be conducted.  Although previous studies have shown that mRNA 
expression of mGluR5 remains the same from P21 through adulthood, the 
immunohistochemical study would determine if the mGluR5 is expressed in the same 
number and location in adolescent and adult DBA/2J mice (Catania et al. 1994).   
As the present study was the first to use MPEP in adolescents, the effects of 
MPEP in adolescent mice remain unknown.  In adults, MPEP is known to increase the 
ethanol-induced loss of righting reflex and to increase time spent in the open arm of the 
elevated plus maze (Sharko and Hodge 2008; Spooren et al. 2000).  Therefore, a study 
of the effectiveness of MPEP in adolescent mice could examine the effect of MPEP on 
ethanol-induced loss of righting reflex or the effect of MPEP in the elevated plus maze.   
Another future study to be conducted is the analysis of phosphorylated ERK1/2 in 
the adult mice following the sucrose-fading/ethanol intake experiment.  We could 
examine directly the hypothesis that long-term changes in pERK1/2 expression underlie 
the effect of SL327 and ethanol during ethanol sensitization to lead to an increase in 
subsequent ethanol intake.     
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Figure 20. Neurocircuitry of Ethanol Sensitization in Adults. 
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Figure 20.  Neurocircuitry following ethanol sensitization in adult DBA/2J mice.  
Proposed changes that occur due to locomotor sensitization in adult mice, adapted from 
Pierce and Kalivas 1993.  Locomotor sensitization occurs following an increase in 
dopaminergic neurotransmission from the VTA to the NAc, along with increases in 
glutamatergic neurotransmission from the PFC to the NAc.  Dashed lines indicate 
decreases in neurotransmission, while bold lines indicate increases. VTA=ventral 
tegmental area; NAc=Nucleus Accumbens; PFC=Prefrontal Cortex; VP=Ventral 
Pallidum; MD Thal=Medial dorsal Thalamus 
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Figure 21. Neurocircuitry During the Adolescent Period. 
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Figure 21.  Neurocircuitry adaptations occurring during the adolescent period of 
development.  Proposed changes occurring in the adolescent include decreases in 
glutamatergic output from the PFC to the VTA and increases in dopaminergic output 
from the VTA to the PFC and NAc.  Dashed lines indicate decreases in 
neurotransmission, while bold lines indicate increases.  VTA=ventral tegmental area; 
NAc=Nucleus Accumbens; PFC=Prefrontal Cortex; VP=Ventral Pallidum; MD 
Thal=Medial dorsal Thalamus 
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Figure 22. Proposed Effect of MPEP on Ethanol Sensitization. 
 
 MD 
Thal PFC 
NAc VP 
VTA 
X
 
 
 
Dopamine = Blue 
Glutamate = Red 
GABA = Black 
 
 
 
 
 
 
X  
 
 
Figure 22:  Effect of MPEP on ethanol sensitization.  In adults, MPEP blocks the critical 
glutamatergic transmission from the PFC to the NAc and the VTA, which inhibits ethanol 
sensitization (shown with the X).  Dashed lines indicate decreases in neurotransmission, 
while bold lines indicate increases.   
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Figure 23. Proposed Regulation of ERK1/2. 
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Figure 23.  Proposed regulation of ERK1/2 phophorylation following ethanol exposure, 
abstinence, and re-exposure.  Chronic ethanol exposure has been shown to 
downregulate the phosphorylation of ERK1/2.  This downregulation is followed by an 
upregulation in ERK1/2 phosphorylation during abstinence from ethanol.  When ethanol is 
re-introduced, there is even greater upregulation of ERK1/2 phosphorylation which may 
underlie a progressive increase in ethanol intake.  Based on Sanna et al 2002. 
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Figure 24. Proposed Long-Term Changes Produced By Ethanol Sensitization. 
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Figure 24.  Proposed long-term changes induced by ethanol or SL327 treatment during 
ethanol sensitization in adult DBA/2J mice.  We propose that treatment with SL327 or 
ethanol during ethanol sensitization significantly inhibits pERK1/2, but that a 
compensatory long-term increase in pERK1/2 leads to increased glutamatergic signaling, 
which might underlie the propensity of the adult mice to self-administer more ethanol.  
Dashed lines indicate decreases in neurotransmission, while bold lines indicate 
increases. 
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